Anchor for securing a suture

Information

  • Patent Grant
  • 8845687
  • Patent Number
    8,845,687
  • Date Filed
    Tuesday, September 17, 2013
    11 years ago
  • Date Issued
    Tuesday, September 30, 2014
    10 years ago
Abstract
An anchor, formed of at least two different materials, for securing a suture relative to bone. The anchor includes a generally cylindrical body portion having a leading end configured to facilitate insertion of the body portion into the bone; a passage which is oriented transverse to the longitudinal axis of the body portion and proximate the leading end of the body portion; and bone engaging projections to secure the anchor in the bone.
Description
BACKGROUND OF THE INVENTION

The present invention relates to a new and improved suture anchor and more specifically to a suture anchor which is capable of expanding in a patient's body to enable the anchor to withstand relatively large pull-out forces.


Anchors are commonly utilized to retain sutures in a patient's body. The anchors have previously been formed of metal, such as stainless steel or titanium. In addition, anchors have been formed of biodegradable materials. These known anchors have relied upon mechanical interlocks between the body tissue and the anchor to retain the anchor in place against the influence of forces transmitted through the suture to the anchor. It has previously been suggested to construct anchors in the manner disclosed in U.S. Pat. Nos. 5,405,359; 5,403,348; 5,203,787; 5,046,513; and 5,041,129. In addition, an anchor formed of body tissue is disclosed in co-pending application Ser. No. 08/626,393 filed Mar. 29, 1996 filed by Peter M. Bonutti and entitled “Suture Anchor”.


SUMMARY OF THE INVENTION

The present invention relates to a new and improved suture anchor which absorbs body liquid. A suture extends from the anchor. The anchor and the suture are inserted into a patient's body. When the anchor is disposed in the patient's body, the anchor expands. The anchor expands by absorbing body liquid and/or by its own natural resilience. As the anchor expands, an improved interlock is obtained between the anchor and the body tissue to enable the anchor to resist relatively large tension forces transmitted through the suture.


The anchor may be formed of a material which absorbs body liquid. Alternatively, the anchor may contain cells which are expanded to absorb body liquid.


The anchor may have a leading end portion which forms an opening in an imperforate body surface. Alternatively, the anchor may be inserted into body tissue through an opening formed in the body tissue by a member other than the anchor. The configuration of the anchor may be changed while the anchor is in the body tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other features of the invention will become more apparent upon a consideration of the following description taken in connection with the accompanying drawings, wherein:



FIG. 1 is a schematic illustration depicting the manner in which an anchor is inserted into a patient's body with a suture extending into the anchor;



FIG. 2 is a schematic illustration depicting the manner in which the anchor of FIG. 1 is pivoted in the patient's body;



FIG. 3 is a schematic illustration depicting the manner in which the patient's body tissue is secured with the anchor immediately after the anchor has been inserted into the patient's body;



FIG. 4 is a schematic illustration, generally similar to FIG. 3, illustrating the manner in which the anchor expands by absorbing body liquid after the anchor has been inserted into the patient's body;



FIG. 5 is a schematic illustration depicting another manner in which the anchor of FIG. 1 may be inserted into a patient's body;



FIG. 6 is a schematic illustration depicting the manner in which the anchor of FIG. 5 expands in the patient's body by absorbing body liquid;



FIG. 7 is a schematic illustration, generally similar to FIG. 1, illustrating the manner in which a second embodiment of the anchor may be inserted into a patient's body through an imperforate surface on body tissue;



FIG. 8 is a schematic pictorial illustration of a third embodiment of the anchor having a portion which absorbs body liquid and a portion which does not absorb body liquid and has projections to engage body tissue;



FIG. 9 is a schematic pictorial illustration of a fourth embodiment of the anchor having a core which absorbs body liquid and a casing formed of an elastic material which does not absorb body liquid;



FIG. 10 is a pictorial schematic illustration of a fifth embodiment of the anchor having an end portion with a suture receiving opening formed in material which does not absorb body liquid and is connected with a main portion which absorbs body liquid;



FIG. 11 is a schematic illustration of a an apparatus for inserting an anchor having cells which are collapsed before the anchor is moved into a patient's body;



FIG. 12 is a schematic illustration of another apparatus for inserting the anchor of FIG. 11 into body tissue;



FIG. 13 is a schematic illustration of the manner in which the configuration of an anchor is changed while the anchor is in the patient's body tissue; and



FIG. 14 is a schematic illustration of another manner in which the configuration of an anchor is changed while the anchor is in a patient's body tissue.





DESCRIPTION OF SPECIFIC PREFERRED EMBODIMENTS OF THE INVENTION

General Description


Suture anchors have previously been utilized to retain sutures in either hard or soft tissue in a human patient's body. The suture anchors have previously been formed of metal, biodegradable materials, and other materials. These known suture anchors have been retained in the patient's body by changing the orientation of the anchor relative to the patient's body once it has been inserted into the patient's body. Alternatively, known anchors have been retained in the patient's body by a mechanical interlock formed with the material of the patient's body by barbs or other projections.


In accordance with one of the features of the present invention, sutures may be retained in a patient's body by anchors which are at least partially formed of material which absorbs body liquid when exposed to the body liquid. The material expands as it absorbs the liquid in the patient's body. As the anchor expands, an improved interlock is formed between the anchor and body tissue of the patient's body. The improved interlock enables relatively large forces to be transmitted through a suture to the anchor.


In accordance with another of the features of the present invention, sutures may be retained in a patient's body by anchors which are formed of material which expands under the influence of its own natural resilience. As the material expands, cells are expanded from a collapsed condition. As the cells expand, the anchor absorbs body liquid by at least partially filling the cells with body liquid. As the anchor expands, an improved interlock is formed between the anchor and tissue of the patient's body. If desired, the material which forms the cells could also absorb body liquid.


In accordance with another feature of the invention, the anchor could be inserted into a patient's body through an imperforate surface on body tissue. This may be done by forming an opening in the body tissue with a leading end portion of the anchor. Alternatively, the opening could be formed by one or more members other than the anchor. Once the anchor has entered the patient's body the configuration of the anchor may be changed under the combined influence of force transmitted to the anchor through the suture and force applied against the outer surface of the anchor by body tissue.


Suture Anchor Formed of Material which Absorbs Body Liquid


A suture anchor 20 (FIG. 1) is formed of a material which absorbs body liquid when the anchor is exposed to body liquid. As the material of the anchor 20 absorbs body liquid, the anchor expands from the initial volume of FIGS. 1-3 to the expanded volume of FIG. 4. As the material of the anchor 20 absorbs body liquid and expands, the volume of the anchor increases and an improved mechanical interlock is formed between the anchor and body tissue in which the anchor has been inserted. The improved interlock enables the anchor 20 to resist large tension forces in a suture 32 without pulling out of body tissue 22.


It is contemplated that the anchor 20 could be completely formed of material which absorbs body liquid. Alternatively, the anchor could be partially formed of material which absorbs body liquid and partially formed of material which does not absorb body liquid. The material which does not absorb body liquid may be provided with projections which are forced into the body upon expansion of the material which absorbs body liquid. This would result in at least two different interlocks being obtained between the anchor and the body tissue, that is, an interlock due to expansion of the material which absorbs body liquid and an interlock due to engagement of projections on the material which does not absorb body liquid with the body tissue.


The suture anchor 20 is entirely formed of material which absorbs body liquid. In one specific instance, the suture anchor 20 was formed of a polymeric material which absorbs body liquid. The polymeric material may be either a copolymer or a dipolymer. The polymeric material may be hydrophilic. The polymeric material may be cellulose, petroylglutamic acid, high purity carboxymethylcellulose, a collagen, or polylactide. It is believed that a ceramic as found in hydroxyapatite composites with polyethylene, polylactide or polyhydroxybutyrate may be utilized to form the anchor 20. Of course, the suture anchor 20 could be formed of other known materials which absorb body liquid.


It is theorized that the hydrophilic material forming the anchor 20 attracts body liquid under the influence of molecular attraction and establishes molecular linkages with the body liquid. The material forming the anchor 20 is body liquid permeable. The body liquid enters minute cavities in the porous material forming the anchor 20 under the influence of capillary action. The attractive forces between molecules of the body liquid and molecules of the material forming the anchor 20 holds the body liquid in the minute cavities in the material forming the anchor.


In the embodiment of the invention illustrated in FIGS. 1-3, the suture anchor 20 has a tubular cylindrical configuration. The suture anchor 20 has a tubular wall 24 formed of material which absorbs body liquid. The tubular wall 24 has a cylindrical outer side surface 26 which is coaxial with a cylindrical inner side surface 28. The cylindrical inner side surface 28 forms a cylindrical passage 30 which extends axially through the center of the suture anchor 20.


The wall 24 of the suture anchor 20 is formed as one piece of a porous hydrophilic polymer which absorbs body liquid. Although it is preferred to form the anchor 20 with a cylindrical configuration, the anchor may be shaped or ground to any one of many different axially tapering or flaring configurations, such as those disclosed in U.S. Pat. No. 5,403,348. It is believed that it may be preferred to form the anchor 20 with either a cylindrical configuration or a polygonal configuration.


Although it is contemplated that the tubular cylindrical suture anchor 20 could be of many different sizes, it is believed that the suture anchor may preferably have a length or axial extent of between 2 and 4 millimeters. The cylindrical outer side surface 26 of the suture anchor 20 may have a diameter of between 1 and 2 millimeters. The cylindrical inner side surface 28 of the passage 30 in the anchor 20 may have a diameter of ½ to 1 millimeter. Of course, the suture anchor 20 could be formed with many different dimensions and/or shapes if desired.


A suture 32 is inserted into the passage 30 in the suture anchor 20. The suture 32 includes a portion or leg 34 which extends away from a flat annular trailing end surface 36 of the anchor 20. In addition, the suture 32 has a second portion or leg 38 which extends across a flat annular leading end surface 40 of the anchor 20. The leg 38 of the suture 32 extends along the cylindrical outer side surface 26 of the anchor 20 to a location adjacent to and spaced from the leg portion 34 of the suture 32. A relatively short portion 44 of the suture 32 interconnects the leg portions 34 and 38 and is disposed in the passage 30 in the suture anchor 20.


An inserter assembly 60 is used to position the suture anchor 20 and a portion of the suture 32 in a patient's body tissue 22. The inserter assembly 60 includes a cylindrical tubular outer sleeve 66 having a cylindrical central passage 68 in which the anchor 20 is disposed. The inserter 60 also includes a cylindrical tubular inner sleeve 72 which is telescopically received in the outer sleeve 66. The tubular inner sleeve 72 has a conical tapered leading end portion 74 which engages an annular trailing end surface 36 of the anchor 20.


The leg or portion 34 of the suture 32 extends through a cylindrical passage 76 in the inner sleeve 72. The leg or portion 38 of the suture 32 extends through the central passage 68 in the outer sleeve 66 along a path which extends between the inner and outer sleeves. The leg or portion 38 of the suture 32 could extend along the outside of the outer sleeve 66. If desired, one of the legs or portions 34 or 38 of the suture could be omitted. If this was done, the suture 32 could be tied or otherwise secured to the anchor 20.


It is contemplated that the anchor 20 may be inserted into a human patient's body at many different locations. The anchor 20 may be inserted into either hard or soft tissue. In the situation illustrated schematically in FIG. 1, the anchor 20 is being inserted into bone tissue 22 in a patient's body. A cylindrical recess 80 is formed in the bone tissue 22 of the patient's body by drilling or other methods. The recess 80 extends through a hard compact outer layer 82 of the patients bone tissue 22 into the relatively porous inner or cancellous tissue 84.


To insert the anchor 20 in the patient's body tissue 22, the cylindrical inner sleeve 72 is moved axially downward (as viewed in FIG. 1) to apply force against a relatively small area on the annular trailing end surface 36 of the anchor 20. Once the anchor 20 has been pushed into the recess 80 by axial movement of the inner sleeve 72 relative to the outer sleeve 66, the leg 38 of the suture 32 is tensioned to apply force against an annular leading end surface 40 of the anchor 20. At the same time, the bevelled leading end 74 of the inner sleeve 72 is pressed against the trailing end-surface 36 of the anchor.


This results in the application of a counterclockwise (as viewed in FIGS. 1 and 2) torque to the anchor 20. This torque causes the anchor 20 to pivot through the orientation shown in FIG. 2 to the orientation shown in FIG. 3. Once the anchor 20 has been pivoted to the orientation shown in FIG. 3, by tensioning the suture 32 and applying force against the anchor with the leading end portion 74 of the inner sleeve 72, the anchor 20 engages the hard compact outer layer 82 of the patient's bone tissue to hold the anchor in the recess 80. Thus, a solid initial interlock is obtained between the anchor 20 and body tissue 22.


The suture 32 is then tensioned to secure a member, such as body tissue 90, in place. The member or body tissue 90 may be soft tissue, or a ligament, or a tendon, or other body tissue. If desired, the suture 32 may be used to secure other members, such as an implant or splint, in place relative to the patient's body tissue 22. The suture is tensioned to transmit force between the anchor 20 and a member to be held in place.


One specific known inserter assembly 60 and method of inserting a suture anchor 20 into a patient's body tissue has been illustrated in FIGS. 1-3. This specific inserter assembly and the method of inserting the anchor 20 are the same as is disclosed in U.S. Pat. No. 5,403,348 issued Apr. 4, 1995 and entitled “Suture Anchor”. However, it is contemplated that many different known types of inserter assemblies could be utilized to install the suture anchor 20 with many different methods in a patient's body tissue. For example, the inserter assembly and method disclosed in U.S. Pat. No. 5,464,426 issued Nov. 7, 1995 and entitled “Method of Closing Discontinuity in Tissue” could be utilized if desired. Of course, other known apparatus and methods could also be utilized if desired.


In accordance with a feature of the invention, the suture anchor 20 absorbs body liquid and expands once the suture anchor has been inserted into the body tissue 22. The expansion of the suture anchor 20 improves the initial interlock between the anchor and body tissue 22. The initial interlock between the anchor 20 and body tissue 22 is obtained by pivoting the anchor in the body tissue to the orientation shown in FIG. 3. The improved interlock is obtained by expanding the anchor 20, as shown in FIG. 4. The improved interlock allows relatively large tension forces to be transmitted through the suture 32 between the anchor 20 and a member to be held in place by the suture.


The suture anchor 20 expands in all directions, from the initial size illustrated in FIG. 3 to a relatively large expanded size illustrated in FIG. 4, shortly after the suture anchor has been inserted into the body tissue 22. After the suture anchor 20 has been inserted into the body tissue 22, the suture anchor is exposed to body liquids, indicated schematically at 98 in FIG. 4. The body liquids 98 are drawn into the suture anchor 20 due to the affinity of the polymeric material forming the suture anchor 20 for body liquids.


As the body liquids 98 are drawn into the suture anchor 20, the anchor expands in a substantially uniform manner in all directions. Thus, the anchor 20 swells both radially and axially. Substantially uniform expansion of the entire outer side surface area of the suture anchor 20 occurs as body liquids 98 are absorbed by the anchor. The extent of expansion of the suture anchor 20 will depend upon the specific characteristics of the material from which the suture anchor is formed and may vary between 10 and 50 percent by volume. Of course, the extent of expansion of the anchor 20 will be a function of the force applied against the outer side surface of the anchor by the body tissue 22.


As the suture anchor 20 swells, the size of the anchor 20 increases. As the size of the anchor 20 increases, the outer side surface of the anchor presses both axially and radially outward against the body tissue 22. As the anchor 20 expands and presses against the body tissue, the body tissue is displaced by the anchor. Thus, the outer side surface of the anchor 20 applies force against the body tissue 22 and moves the body tissue to make room for the anchor as the anchor expands. If the anchor 20 encounters a localized area of high resistance to expansion in the body tissue, the anchor will expand around the localized area and may even shift in the body tissue 22.


The expansion of the anchor 20 as it absorbs the body liquids 98 results in an increasing mechanical interlocking action between the anchor 20 and the body tissue 22. There is an initial mechanical interlock between the anchor 20 and the body tissue 22 when the anchor has its original or initial size (FIG. 3). As body liquids 98 are absorbed by the suture anchor 20 and the volume of the anchor increases, the anchor expands to improve the mechanical interlock between the anchor and the body tissue 22. The improved interlock between the anchor 20 and body tissue 22 allows relatively large tension forces to be transmitted through the suture 32 without pulling the anchor out of the body tissue.


Installation—Second Procedure


In the embodiment of the invention illustrated in FIGS. 1-4, the anchor 20 was pivoted from the orientation shown in FIG. 1 through the orientation shown in FIG. 2 to the orientation shown in FIG. 3 to obtain an initial mechanical interlock between the anchor and body tissue 22. In the embodiment of the invention illustrated in FIGS. 5 and 6, the anchor is not pivoted from its initial orientation to obtain an initial mechanical interlock. The anchor is merely positioned in the body tissue and expanded in all directions by absorbing body liquid. The expansion of the anchor results in the formation of an interlock between the anchor and the body tissue. Since the embodiment of the invention illustrated in FIGS. 5 and 6 is generally similar to the embodiment of the invention illustrated in FIGS. 1-4, similar numerals will be utilized to designate similar components, the suffix letter “a” being associated with the numerals of FIGS. 5 and 6 in order to avoid confusion.


The suture anchor 20a has the same construction and is formed of the same hydrophilic polymeric material as the suture anchor 20 of FIGS. 1-3. The suture anchor 20a (FIG. 5) has a cylindrical tubular configuration. The suture anchor 20a has a cylindrical outer side surface 26a. A cylindrical central passage 30a extends through the suture anchor 20a between opposite annular end surfaces 36a and 40a of the suture anchor 20a.


A suture 32a has a leg 34a which extends through a passage 76a formed in an inner sleeve 72a. A second leg 38a of the suture 32a extends through a central passage 68a and a tubular outer sleeve 66a. The leg 38a of the suture 32a extends between a cylindrical inner side surface 68a of the inner sleeve 72a and a cylindrical inner side surface of the outer sleeve 66a.


It is contemplated that the anchor 20a maybe inserted into a patient's body at many different locations. The anchor 20a may be inserted into either hard or soft tissue. In the situation illustrated schematically in FIG. 5, the anchor is being inserted-into bone tissue 22a in a patient's body with the inserter assembly 60a. A recess 80a is formed in the bone tissue 20a of the human patient's body by drilling or other methods. The cylindrical recess 80a extends through the hard compact outer layer 82a of the patient's bone tissue 20a into the relatively porous inner or cancellous tissue 84a.


To insert the anchor 20a in the patient's body tissue 22a, the inner sleeve 72a is moved axially downward (as viewed in FIG. 5) to apply force against the trailing end surface 36a of the anchor 20a. In this embodiment of the inserter assembly 60a, the inner sleeve 72a has a cylindrical leading end portion 74a which applies a substantially uniform force over substantially the entire flat annular trailing end surface 36a of the anchor 20a. Therefore, the anchor 20a is not pivoted but is merely moved straight into the recess 80a.


Once the anchor 20a has been positioned in the recess 80a, the anchor absorbs body liquid 98a and increases in volume as the liquid is absorbed. This results in the anchor expanding in all directions from the initial size of FIG. 5 to a relatively large expanded size illustrated in FIG. 6. As the anchor 20a expands, its size increases by 10 to 50 percent by volume.


The anchor 20a is porous and is formed of a hydrophilic material. The body liquid 98a is drawn into openings in the porous material of the anchor 20a by the affinity of the porous material forming the anchor for the body liquid. The attractive forces between the material forming the anchor 20a and the body liquid holds the body liquid in the anchor.


As the anchor 20a expands from the initial size, the outer surfaces on the anchor press radially and axially against the body tissue 22a. Substantially uniform expansion of the anchor 20a forms a secure mechanical interlock with the body tissue. This interlock enables tension forces to be transmitted through the suture 32a between the anchor 20a and a member, such as the body tissue 90a.


As the anchor 20a expands radially outward, the cancellous tissue 84a is compressed and the size of the portion of the recess 80a in the cancellous tissue 84a is increased. As this happens, the diameter of the cylindrical anchor 20a increases from a diameter which is just slightly less than the size of the portion of the recess 80a which extends through the hard compact outer layer 82a of the bone tissue 22a to a diameter which is greater than the diameter of the portion of the recess 80a extending through the hard compact outer layer 82a of bone tissue. This results in the anchor 20a being locked in place in the body tissue 22a.


The suture 32a can then be used to secure a member 90a in place in the manner illustrated schematically in FIG. 6. The member 90a may be soft body tissue, or a ligament, or a tendon, or other body tissue. If desired, the suture 32a may be used to secure an implant or splint in place relative to the patient's body 22a. The interlock between the anchor 20a and body tissue 22a enables substantial tension force to be transmitted through the suture 32a without pulling the anchor out of the body tissue.


The expansion of the anchor 20a has been schematically illustrated in FIG. 6 as being uniform in all directions. This will be the case when the body tissue 22a applies uniform forces against all sides of the anchor 20a. However, the body tissue 22a may provide nonuniform resistance to expansion of the anchor 20a. When this occurs, the anchor 20a may shift in the body tissue 22a under the influence of forces applied against the body tissue as the anchor expands. In addition or alternatively, the anchor 20a may expand in a nonuniform manner.


Anchor—Second Embodiment


In the embodiment of the invention illustrated in FIGS. 1-4, the anchor 20 has a generally cylindrical configuration and is formed entirely of a hydrophilic polymeric material which absorbs body liquid. The anchor illustrated in FIGS. 1-4, due to its relatively blunt leading end portion, is particularly well adapted for positioning in preformed recesses in body tissue. In the embodiment of the anchor illustrated in FIG. 7, the anchor has a sharp or pointed leading end portion to facilitate forming an opening in imperforate body tissue. Since the embodiment of the invention illustrated in FIG. 7 is generally similar to the embodiment of the invention illustrated in FIGS. 1-4, similar numerals will be utilized to designate similar components, the suffix letter “b” being associated with the numerals of FIG. 7 to avoid confusion.


The tubular cylindrical suture anchor 20b has a generally cylindrical outer side surface 26b which is coaxial with a cylindrical inner side surface 28b. The cylindrical inner side surface 28b forms a portion of a passage 30b which extends through the anchor 20b. In addition to the main portion of the passage 30b formed by the cylindrical side surface 28b, a second cylindrical side surface 110 has a central axis which extends perpendicular to the central axis of the cylindrical side surface 28b. The cylindrical side surface 110 intersects the cylindrical side surface 28b and extends radially outward from the cylindrical side surface 28b. The cylindrical side surfaces 28b and 110 cooperate to form the passage 30b with a generally L-shaped configuration.


A suture 32b is inserted into the passage 30b in the suture anchor 20b. The suture 32b includes a portion or leg 34b which extends away from a flat annular trailing end surface 36b of the anchor 20b. In addition, the suture 32b has a second portion or leg 38b which extends along the cylindrical outer side surface 26b of the anchor 20b and along the cylindrical inner side surface 68b of the outer sleeve 66b. A relatively short portion 44b of the suture 32b interconnects the leg portions 34b and 38b and is disposed in the passage 30b in the suture anchor 20b.


An inserter assembly 60b is used to position the suture anchor 20b and a portion of the suture 32b in a patient's body tissue 22b. The inserter assembly 60b includes a generally cylindrical tubular outer sleeve 66b having a central passage 68b in which the anchor 20b is disposed. The inserter 60b also includes a tubular inner sleeve 72b which is telescopically received in the outer sleeve 66b. The tubular inner sleeve 72b has a conical tapered leading end portion 74b which engages the trailing end surface 36b of the anchor 20b.


In accordance with a feature of the embodiment of the invention illustrated in FIG. 7, the anchor 20b has a leading end portion 112 with a generally conical configuration. The leading end portion 112 of the anchor 20b is adapted to form an opening in an imperforate outer side surface 114 of the patient's body tissue 22b. In addition, the leading end portion 112 of the anchor 20b facilitates moving the anchor into the body tissue 22b under the influence of force applied against the trailing end surface 36b of the anchor 20b by the tubular inner sleeve 72b. The conical leading end portion 112 of the anchor 20b is formed by a conical layer of a relatively hard polymeric material. The polymeric material forming the leading end portion 112 may be biodegradable if desired.


In addition, the anchor 20b has a cylindrical body portion or wall 116 which is disposed in a coaxial relationship with the leading end portion 112. The cylindrical body portion 116 is formed of a hydrophilic polymeric material which absorbs body liquid when exposed to the body liquid. The cylindrical body portion 116 is formed of the same material as the anchor 20 of FIGS. 1-4. As the body portion 116 of the anchor 20b absorbs body liquid, the body portion of the anchor expands radially and axially to interlock with the body tissue 22b. The leading end portion 112 is formed of a rigid polymeric material which does not absorb body liquid. The leading end portion 74b of the tubular inner sleeve 72b is tapered so that it applies force against the trailing end surface 36b of the anchor 20b at a relatively small area on the trailing end surface. The concentrated application of force to the trailing end surface 36b of the anchor 20b facilitates pivoting movement of the anchor in the body tissue 22b upon tensioning of the leg 38b of the suture 32b.


Assuming the anchor 20b is to be moved into body tissue 22b disposed beneath a layer 120 of skin, force is applied against the tubular inner sleeve 72b to force the pointed leading end portion 112 of the anchor against the imperforate outer side surface 114 of the skin 120. This force causes the anchor 20b to pierce the skin 120 and enter soft body tissue 122 disposed beneath the skin. Once the anchor 20b has been moved completely beneath the skin 120 into the soft body tissue 122, the leg 38b of the suture 32b is tensioned. This results in the application of torque to the anchor 20b tending to rotate or pivot the anchor in a counterclockwise direction from the orientation shown in FIG. 7 to a generally horizontal orientation, corresponding to the orientation of the anchor illustrated in FIG. 3. At this time, the longitudinal central axis of the anchor will be generally parallel to the skin 120.


Once the anchor 20b has been moved into the body tissue 122 and pivoted in the manner previously explained, the body portion 116 of the anchor will absorb body liquid, such as blood or other fluids. As the hydrophilic body portion 116 of the anchor 20b absorbs body liquids, the body portion expands in all directions and presses against the body tissue 122. As the anchor expands, body tissue is displaced and the mechanical interlock with the anchor 20b is enhanced.


Thus, the anchor 20b is mechanically interlocked with the body tissue 122 by both pivotal movement of the anchor to a sidewise orientation and expansion of the anchor as it absorbs body liquids. The improved interlock obtained by expanding the anchor 20b enables relatively large tension forces to be transmitted between a member (not shown) and the anchor 20b through the suture 32b.


Anchor—Third Embodiment


In the embodiment of the anchor illustrated in FIGS. 1-4, the anchor is formed entirely of material which absorbs body liquid when it is exposed to the body liquid. In the embodiment of the anchor illustrated in FIG. 8, a portion of the anchor is formed of material which absorbs body liquid and another portion of the anchor is formed of material which does not absorb body liquid. The material which does not absorb body liquid has projections which engage body tissue to enhance an interlock between the anchor and the body tissue. Since the embodiment of the invention illustrated in FIG. 8 is generally similar to the embodiment of the invention illustrated in FIGS. 1-4, similar numerals will be utilized to designate similar components, the suffix letter “c” being associated with the numerals of FIG. 8 in order to avoid confusion.


An anchor 20c (FIG. 8) has a tubular cylindrical configuration. A suture (not shown) extends through a central passage 30c in the anchor 20c in the same manner as illustrated in FIG. 1 for the anchor 20.


In accordance with a feature of this embodiment of the invention, the anchor 20c (FIG. 8) has a body portion 116c which is formed of a hydrophilic polymeric material which absorbs body liquid when exposed to the body liquid. In addition, the anchor 20c includes a plurality of identical retaining portions 130, 132 and 134. The retaining portions 130, 132 and 134 are formed of a relatively hard polymeric material which does not absorb body liquid. The retaining portions 130, 132 and 134 may be biodegradable if desired.


in the illustrated embodiment of the invention, the retaining portions 130, 132 and 134 and a plurality of ribs or projections 138 which extend outward from the retaining portion. When the anchor 20c is positioned in body tissue in the manner previously explained in conjunction with the embodiments of the invention illustrated in FIGS. 1-4, the body portion 116c absorbs body liquid. When this occurs, the body portion 116c of the anchor 20c expands radially and axially outward to enhance the mechanical interlock with the body tissue.


As the body portion 116c of the anchor 20c expands, the retaining portions 130, 132 and 134 are moved radially outward away from the central axis of the anchor 20c. This presses the ribs 138 on the retaining portions 130, 132 and 134 into the body tissue to further enhance the mechanical interlock between the anchor and the body tissue. Although the ribs 138 have been shown in FIG. 8 as having a generally arcuate configuration and a generally smooth outer side surface, it is contemplated that the ribs could have barbs or other projections which would impale the body tissue as the body portion 116c of the anchor 20c absorbs body liquid and expands. Of course, this would further enhance the mechanical interlock between the anchor 20c and the body tissue.


In the embodiment of the anchor 20c illustrated in FIG. 8, the anchor has a generally flat annular leading end portion. However, it is contemplated that the anchor 20c could be provided with a conical leading end portion, similar to the conical leading end portion 112 on the anchor 20b of FIG. 7. If the anchor 20c were to be provided with a conical leading end portion, it is contemplated that the retaining portions 130, 132 and 134 could be extended in an axial direction to form the conical leading end portion as three separate segments. As the body portion 116c of the anchor 20c absorbs body liquid and expands, the retaining portions 130, 132 and 134 would move radially outward away from each other and the leading end portion of the anchor would expand.


A relatively strong interlock is obtained between the anchor 20c and body tissue. This interlock is obtained by changing the orientation of the anchor 20c relative to the body tissue, in the manner illustrated for the anchor 20 in FIG. 2. In addition, the interlock is obtained by expansion of the anchor 20c as the body portion 116c absorbs body liquid. The interlock is also obtained by engagement of the ribs 138 with body tissue. The result is a strong interlock which enables the anchor 20c to resist very large tension forces transmitted to the anchor through a suture.


Anchor—Fourth Embodiment


In the embodiment of the anchor 20 illustrated in FIGS. 1-4, the anchor is formed entirely of material which expands when it is exposed to body liquid. In the embodiment of the invention illustrated in FIG. 9, the anchor is formed by a core of material which expands upon being exposed to body liquid and an elastic jacket which encloses the core. Since the embodiment of the invention illustrated in FIG. 9 is generally similar to the embodiment of the invention illustrated in FIGS. 1-4, similar numerals will be utilized to designate similar components, the suffix letter “d” being associated with the numerals of FIG. 9 in order to avoid confusion.


An anchor 20d (FIG. 9) has a cylindrical configuration. The anchor 20d includes a cylindrical core 144 which is enclosed by a tubular cylindrical jacket 146. A passage 30d extends through both the core 144 and the jacket 146. The passage 30d extends diametrically through the core 144 and the jacket 146 and has a cylindrical configuration. A suture (not shown) is positioned in the passage 30d. The suture may be tied off at one end of the passage or may extend through the passage so that legs of the suture extend along opposite sides of the jacket 146.


The jacket 146 is provided with a plurality of circular openings 150 which extend through the jacket. The openings 150 enable body liquid to pass through the jacket into the core 144. The jacket 146 is formed of an elastic polymeric material which is easily stretched. The core 144 is formed of a material which absorbs body liquid upon being exposed to the body liquid. In one specific embodiment of the suture anchor 20d, the core 144 was formed of a hydrophilic polymeric material which is the same as the material forming the anchor 20 of FIGS. 1-4.


When the anchor 20d is inserted into body tissue, in the manner illustrated schematically in either FIGS. 1-3 or 5 and 6, the entire anchor 20d is exposed to body liquid. The body liquid passes through the openings 150 and is absorbed by the core 144. As the core 144 absorbs body liquid, the core expands and stretches the jacket 146.


Although the anchor 20d has been shown as having a generally cylindrical configuration with flat annular end surfaces, it is contemplated that the anchor could be provided with a conical leading end portion, similar to the conical leading end portion 112 of the anchor 20b of FIG. 7. The conical leading end portion could be formed either as a portion of the jacket 46 or separately from the jacket. It is believed that it may be preferred to form a conical leading end portion for the anchor 20d separately from the jacket 146 to enable the leading end portion to be formed of a hard material which is not readily stretched and which is capable of piercing an imperforate surface of body tissue.


In the illustrated embodiment of the invention, the jacket 146 is formed of a material which is resiliently stretched when the core 144 absorbs body liquid and expands. It is contemplated that the size of the jacket 146 could be increased in other ways to accommodate expansion of the core. For example, releasable tucks could be formed in the jacket. Upon expansion of the core, stitches or other devices holding the tucks would be released under the influence of force applied against the jacket by the core.


Anchor—Fifth Embodiment


The anchors illustrated in FIGS. 1-9 all have passages through which the suture extends. In the embodiment of the invention illustrated in FIG. 10, the anchor has an eyelet through which the suture extends. Since the embodiment of the invention illustrated in FIG. 10 is generally similar to the embodiment of the invention illustrated in FIGS. 1-9, similar numerals will be utilized to designate similar components, the suffix letter “e” being associated with the embodiment of the invention illustrated in FIG. 10 to avoid confusion.


An anchor 20e has a solid cylindrical body portion 116e. The body portion 116e of the anchor 20e is formed of a hydrophilic polymeric material which absorbs body liquid when exposed to the body liquid. The material forming the body portion of the anchor 20e is the same as the material forming the anchor 20 of FIGS. 1-4. Upon absorbing body liquid, a portion 116e of the anchor 20e expands.


In accordance with a feature of the embodiment of the invention illustrated in FIG. 10, the anchor 20e is provided with a trailing end portion 160 which is connected with a suture. The trailing end portion 160 of the anchor 20e has a circular wall 162 which is fixedly connected with the body portion 116e of the anchor 20e. A passage 30e is formed in a projection 164 which extends axially outward from the end wall 162. The passage 30e receives a suture. The suture may be tied off on the projection 164 or may extend through the projection and have a pair of legs, corresponding to the legs 34 and 38 of the suture 32 of FIG. 1.


When the anchor 20e is inserted into body tissue, using an inserter assembly similar to the inserter assembly 60 of FIGS. 1 and 2, the body portion 116e is exposed to body liquid. This results in the body portion 116e of the anchor 20e expanding radially and axially outward from the trailing end portion 160 to form a mechanical interlock with the body tissue.


Anchor—Sixth Embodiment


In the embodiments of the invention illustrated in FIGS. 1-10, at least portions of the anchors are formed of a hydrophilic polymeric material which absorbs body liquid. In the embodiment of the invention illustrated in FIG. 11, the anchor is formed of cellular material which absorbs body liquid. Since the embodiment of the invention illustrated in FIG. 11 is generally similar to the embodiments of the invention illustrated in FIGS. 1-10, similar numerals will be utilized to designate similar components, the suffix letter “f” being associated with the numerals of FIG. 11 to avoid confusion.


A suture anchor 20f has a tubular cylindrical configuration when the anchor is in an unrestrained condition. When the suture anchor 20f is in an unrestrained condition, the anchor has a tubular wall 24f which has a cylindrical outer side surface 26f which is coaxial with a cylindrical inner side surface 28f of the anchor. The cylindrical inner side surface 281 forms a passage 30f which extends axially through the center of the suture anchor 20f when the anchor is in an unrestrained condition.


The wall 24f of the suture anchor 20f is formed as one piece of resilient material containing a large number of cells which are expandable to absorb body liquid. The cellular material which forms the suture anchor 20f may be a hydrophilic polymeric cellular material which absorbs body liquid. Although it is preferred to form the anchor 20f with a cylindrical configuration, the anchor may be shaped to any one of many different axially tapering or flaring configurations or may have a polygonal configuration.


A suture 32f is inserted into the passage 30f in the suture anchor 20f. The suture 32f includes a leg portion 34f which extends away from a flat annular trailing end surface 36f of the anchor 20f. In addition, the suture 32f has a second portion or leg 38f which extends across a flat annular leading end surface 40f of the anchor 20f. The leg 38f of the suture 32f extends along the cylindrical outer side surface 26f. A relatively short portion 44f of the suture 32f interconnects the leg portion 34f and 38f and is disposed in the passage 30f in the anchor 20f.


An inserter assembly 60f is used to position the anchor 20f and a portion of the suture 32f in a patient's body tissue 22f. The inserter assembly 60f includes a cylindrical tubular outer sleeve 66f having a cylindrical passage 68f in which the anchor 20f is disposed. The inserter 60f also includes a cylindrical tubular inner sleeve 72f which is telescopically received in the outer sleeve 66f. The tubular inner sleeve 72f has a cylindrical leading end portion 74f which engages the trailing end surface 36f of the anchor 20f.


The leading end portion 74f of the tubular inner sleeve 72f has an end wall 168 with a flat end surface which abuttingly engages the flat annular trailing end surface 36f on the anchor 20f. The two legs 34f and 36f of the suture 32f extend through a central opening formed in the end wall 168 at the leading end portion 74f of the inner sleeve 72f. The legs 34f and 38f of the suture 32f extend through the tubular inner sleeve 72f to a location remote from the inserter assembly 60f. If desired, one of the legs 34f or 38f of the suture could be omitted. If this was done, the suture 32f could be tied or otherwise secured to the anchor 20f.


It is contemplated that the anchor 20f may be inserted into a human patient's body at many different locations. The anchor 20f may be inserted into either hard or soft tissue. In the situation illustrated schematically in FIG. 11, the anchor 20f is being inserted into soft body tissue in a patient's body.


To facilitate insertion of the anchor 20f into soft body tissue, a leading end portion 170 of the outer sleeve 60f has an axially tapered or pointed configuration. The pointed configuration of the leading end portion 170 of the outer sleeve 601 enables the leading end portion of the outer sleeve to form an opening in an imperforate outer side surface 114f of the patient's body tissue 22f. In addition, the pointed leading end portion 170 of the outer sleeve 60f facilitates moving the outer sleeve 60f into the body tissue 22f under the influence of force manually applied against an outer end portion of the outer sleeve 60f.


To insert the anchor 20f into the patient's body tissue 22f, the pointed leading end portion 170 of the outer sleeve 66f is pressed against the imperforate outer side surface 114f of skin or other tissue 120f. The pointed leading end portion of the outer sleeve 661 pierces the imperforate outer surface 114f of the skin 120f and enters soft body tissue 122f disposed beneath the skin. The outer sleeve 66f is forced into the soft body tissue 22f for a desired distance corresponding to the distance which the suture anchor 20f is to be inserted into the body tissue.


The inner sleeve 72f is then pressed downward (as viewed in FIG. 11) to move the suture anchor 20f to the leading end portion 170 of the outer tubular member 66f. The inner side surface 68f of the tubular outer member 66f applies force against the outer side surface 26f of the anchor 20f to maintain the anchor in the compressed condition shown in FIG. 11. The outer tubular member 66f is then moved axially upward (as viewed in FIG. 11) relative to the stationary inner tubular member 72f. This results in the anchor 20f being ejected from the outer tubular member 66f into the body tissue 22f. Once the anchor 20f has moved from the outer sleeve 66f into the body tissue 22f, both the inner and outer sleeves 66f and 72f are withdrawn from the body tissue.


If desired, a pointed member, such as a trocar, could be inserted through the outer sleeve 66f to pierce the surface 114f and body tissue 22f. If this was done, the inner sleeve 72f and anchor 20f would be removed from the outer sleeve 66f to provide room for the pointed member. After the body tissue has been pierced by the pointed member, the pointed member would be withdrawn from the outer sleeve 66f and the inner sleeve 72f and compressed anchor 20f inserted into the outer sleeve.


In accordance with a feature of the present invention, the anchor 20f is formed of a resilient cellular material. Prior to insertion of the anchor 20f into the outer sleeve 66f, the cellular material of the anchor 20f is resiliently compressed from a relatively large unrestrained size to a compacted size illustrated in FIG. 11. The unrestrained size of the suture anchor 20f may be 2 to 20 times as large as the size illustrated in FIG. 11.


As the resilient cellular material of the anchor 20f is compressed, the passage 30f which extends through the anchor 20f when the anchor is in its unrestrained condition, is collapsed tightly inward against the portion 44f of the suture 32f. In addition, as the anchor 20f is resiliently compressed from its unrestrained condition, the cells in the anchor are collapsed. Thus, the anchor 20f is resiliently compressed from an unrestrained condition to the compacted or compressed condition of FIG. 11 in much the same manner as in which a sponge may be compressed.


The compressed anchor 20f, with the suture 32f extending through the anchor and the inner sleeve 72f, is inserted into the outer sleeve 66f. The inner sleeve 72f then pushes the compressed anchor axially downward (as viewed in FIG. 11) into the outer sleeve as the telescopic relationship between the inner and outer sleeves is increased.


When the anchor 20f is in the outer sleeve 66f, the inner side surface 68f of the outer sleeve applies force against the outer side surface 26f of the anchor to hold the anchor in its compressed condition. Upon movement of the anchor 20f out of the outer sleeve 66f into the body tissue 22f, the force holding the anchor 20f in a compressed condition is removed from the outer side surface 26f of the anchor. As this occurs, the natural resilience of the cellular material forming the anchor 20f causes the anchor to expand.


As the anchor 20f expands, the anchor applies force against the soft body tissue 122f and increases the size of the cavity which was originally formed by the outer sleeve 66f of the inserter assembly 60f. As the anchor 20f expands, it applies force against the soft body tissue 122f and displaces the soft body tissue. Thus, the outer side surface 26f of the anchor 20f is pressed against the soft body tissue 122f and moves the soft body tissue as the anchor expands radially outward.


As the anchor 20f expands, the cells in the anchor are expanded from a collapsed condition to an expanded condition. As the size of the cells in the anchor 20f increases, body liquids are drawn into the cells. Thus, the anchor 20f absorbs body liquid as it expands.


The anchor 20f is formed of a resilient polymeric material having an open cell, sponge-like construction. When the anchor 20f is in the compressed condition illustrated in FIG. 11, the cells are collapsed. As the anchor 20f expands in the body tissue 22f, the cells expand. Since the anchor 20f has an open cellular construction, body liquid can flow into the cells as the anchor expands.


Once the anchor 20f has expanded in the body tissue 22f, the expanded anchor is substantially larger than the opening which was formed in the body tissue by insertion of the outer sleeve 66f into the body tissue. However, it should be understood that due to force applied against the anchor 20f by the body tissue 22f, the anchor may not expand fully back to its unrestrained size. As the outer sleeve 66f is withdrawn from the body tissue, the visco-elastic nature of the body tissue causes the body tissue to come together and close off the passage which was formed by the insertion of the outer sleeve 66f into the body tissue. Thus, the body tissue will move inward and grip the legs or portions 34f and 38f of the suture 32f. The anchor 20f will fill a cavity formed in the body tissue 22f by expansion of the anchor.


The expansion of the anchor 20f in the body tissue results in the formation of an interlock between the anchor and the body tissue to prevent the anchor from being pulled out of the body tissue under the influence of tension applied to the suture 32f. The suture 32f may be used to position a member which is body tissue, in the manner similar to that illustrated in FIGS. 3 and 4, or may be used to position a splint or implant member relative to the body tissue. Since the expanded anchor 20f has a firm interlock with the body tissue 122f, tension forces transmitted through the suture 32f between the anchor 20f and a member held in place by the suture will not pull the anchor 20f out of the body tissue.


In FIG. 11, the compressed suture anchor 20f is being inserted into a solid mass of soft body tissue 122f. However, it is contemplated that the suture anchor 20f could be inserted into either a natural or artificial body cavity. If this was done the suture anchor 20f would expand to at least partially fill the body cavity.


Alternative Anchor Insertion Apparatus


In the embodiment of the invention illustrated in FIG. 11, the anchor 20f moves through the open end portion 170 of the outer sleeve 66f into the body tissue 22f. In the embodiment of the invention illustrated in FIG. 12, the outer sleeve has a closed pointed end portion and the anchor is moved from the outer sleeve at a location immediately behind the pointed end portion of the outer sleeve. Since the embodiment of the invention illustrated in FIG. 12 is generally similar to the embodiment of the invention illustrated in FIG. 11 similar numerals will be utilized to designate similar components, the suffix letter “g” being associated with the numerals of FIG. 12 to avoid confusion.


An anchor 20g has the same construction and is formed of the same resilient open cell material as the anchor 20f of FIG. 11. A suture 32g has a leg or portion 34g which extends from a flat annular trailing end surface 36g of the cylindrical anchor 20g. A second leg or portion 38g of the suture 32g extends from a flat annular leading end surface 40g of the anchor 20g. A portion 44g of the suture 32g extends through the anchor and interconnects the legs or portions 34g and 38g.


The two legs or portions 34g and 38g of the suture 32g extend through a cylindrical central passage in an outer sleeve 72g of an inserter assembly 60g. The inner sleeve 72g is disposed in a telescopic relationship with a cylindrical outer sleeve 66g of the inserter assembly 60g. The inner sleeve 72g cooperates with the outer sleeve 66g in the same manner as previously explained in conjunction with the inserter assembly of FIG. 11.


In accordance with a feature of this embodiment of the invention, the outer sleeve 66g has a solid pointed end portion 170g with a generally conical configuration. The pointed end portion 170g is utilized to pierce an imperforate surface of body tissue in much the same manner as in which the end portion 170 of the outer sleeve 66f of the inserter assembly 60f (FIG. 11) is used to pierce an imperforate surface 114f of the body tissue 22f.


In accordance with one of the features of the present invention, the outer sleeve 66g has a generally oval opening 180 in a cylindrical outer side surface 182 of the outer sleeve 66g. The opening 180 is connected with a central passage 68g. The passage 68g extends from an open upper (as viewed in FIG. 12) end portion of the outer sleeve 66g to the solid pointed leading end portion 170g.


When the outer sleeve 66g has been inserted to the desired depth in body tissue, the inner sleeve 72g is moved axially downward (as viewed in FIG. 12) and the anchor 20g is forced along an arcuate cam surface 184 leading to the opening 180. This results in the anchor 20g being forced from the passage 68g in the outer sleeve 66g into the soft body tissue. As this occurs, the leading end 40g of the anchor 20g applies force against the body tissue to displace the body tissue and provide space for the anchor.


As the anchor 20g moves along the passage 68g and through the opening 180, the orientation of the anchor relative to the body tissue changes. Thus, the orientation of the anchor 20g changes from the orientation shown in FIG. 12 to an orientation similar to the orientation of the anchor 20 in FIG. 3. This pivotal movement of the anchor 20g results in the anchor moving from an initial orientation in which a central axis of the anchor extends parallel to and is coincident with a central axis of the outer sleeve 66g to an orientation in which the central axis of the anchor 20g extends perpendicular to the central axis of the outer sleeve 66g.


As the anchor 20g exits from the passage 68g in the outer sleeve 66g, the anchor 20g expands under the influence of its own natural resilience and further displaces body tissue. Once the inner sleeve 72g has been moved downward to the maximum extent possible, that is, to a position in which the leading end of the inner sleeve 72g engages the cam surface 184, the inner and outer sleeves are withdrawn together from the body tissue. As this occurs, engagement of the anchor 20g with the body tissue causes the trailing end portion of the anchor to move out of the passage 68g in the outer sleeve 66g.


As the outer sleeve 66g continues to be withdrawn, the pointed leading portion 170 of the outer sleeve moves upward (as viewed in FIG. 12), past the anchor 20g. As this occurs, the anchor 20g expands into the space previously occupied by the leading end portion 170g of the outer sleeve 66g. As the outer sleeve 66g and inner sleeve 72g are withdrawn from the body tissue, the visco-elastic body tissue closes around the anchor 20g and the legs 34g and 38g of the suture 32g.


As the anchor 20g is forced from the outer sleeve 66g into the body tissue and expands, cells in the anchor 20g also expand. As the cells in the anchor 20g expand, body liquid is drawn into and at least partially fills the cells in the anchor. The anchor 20g has an open cellular construction, similar to the construction of a sponge. The anchor 20g is resiliently compressed prior to insertion into the outer sleeve 66g so that the cells in the anchor 20g are resiliently collapsed until the anchor is allowed to expand as it is forced out of the side opening 180 in the outer sleeve 66g.


Changing Configuration of Anchor


In the embodiment of the invention illustrated in FIGS. 1-3, the general configuration of the anchor 20 is illustrated as being maintained constant. Thus, the anchor 20 has a cylindrical tubular configuration with a linear central axis. In the embodiment of the invention illustrated in FIG. 13, the configuration of the anchor is changed while the anchor is in a patient's body tissue. Since the embodiment of the invention illustrated in FIG. 13 is generally similar to the embodiment of the invention illustrated in FIGS. 1-4, similar numerals will be utilized to designate similar components, the suffix letter “h” being associated with the numerals of FIG. 13 to avoid confusion.


A suture anchor 20h has the same construction and is formed of the same hydrophilic polymeric material as the suture anchor 20 of FIGS. 1-3. The suture anchor 20h (FIG. 13) has a cylindrical tubular configuration. The suture anchor 20h has a cylindrical outer side surface 26h. A cylindrical central passage (not shown) extends through the suture anchor 20h between opposite annular end surfaces 36h and 40h of the suture anchor 20h.


A suture 32h has a leg 34h which extends from an annular end surface 36h of the anchor 20h. A second leg 38h of the suture 32h extends from the opposite end surface 40h of the anchor 20h. The anchor 20h is inserted into body tissue 20h in the same manner as in which the anchor 20f of FIG. 11 is inserted into the body tissue 22f. Thus, an inserter assembly, similar to the inserter assembly 60f of FIG. 11, is used to position the anchor 20h in the body tissue 22h. The inserter assembly may include a tubular outer sleeve, corresponding to the sleeve 66f of FIG. 11 and a tubular inner sleeve, corresponding to the inner sleeve 72f of FIG. 11. However, the inner sleeve 72f is provided with a conical leading end portion having a configuration corresponding to the configuration of the leading end portion 74 (FIG. 1) of the inner sleeve 72. This enables the inserter assembly to pivot the suture anchor 20h to the position shown in FIG. 13.


The outer sleeve of the inserter assembly which is used to position the anchor 20h in the body tissue 22h has a pointed leading end portion, corresponding to the pointed leading end 170 of the outer sleeve 66f of the inserter assembly 60f of FIG. 11. The pointed leading end of the outer sleeve of the inserter assembly was used to pierce the imperforate outer side surface 114h of skin 120h and to enter soft body tissue 122h.


As the anchor 20h was positioned in the soft body tissue 122h, the opposite legs 34h and 38h of the suture 32h were tensioned. This resulted in the suture 32h applying force against the opposite flat annular end surfaces 36h and 40h of the anchor 20h. The force applied to opposite ends of the anchor 20h by the suture 32h pulled the outer side surface 26h of the anchor against the body tissue 122h. In addition, the force applied against opposite ends of the anchor 20h by the suture 32h caused the suture to bend from an initial configuration to the deflected configuration shown in FIG. 13.


When the anchor 20h was in the initial configuration, the anchor 20h had a straight longitudinal central axis, the same as the anchor 20 of FIGS. 1-3. However, tensioning the suture 32h caused the legs 34h and 38h of the suture to apply force against opposite ends of the anchor 20h and pull the anchor against the body tissue 122h. As this occurred, the anchor was deflected to the arcuate configuration illustrated in FIG. 13. Since the anchor 20h is formed of the same hydrophilic polymeric material as the anchor 20 of FIGS. 1-3, the anchor 20h absorbs body fluid and expands in the body tissue 122h while the anchor has the deflected configuration illustrated in FIG. 13.


Deflection of Anchor—Second Embodiment


In the embodiment of the invention illustrated in FIG. 13, the configuration of the anchor 20h is changed from an initial configuration in which the anchor has a straight longitudinal central axis to a configuration in which the anchor has an arcuate longitudinal central axis by tensioning the suture 32h to apply force against opposite ends of the anchor. In the embodiment of the invention illustrated in FIG. 14, the configuration of the anchor is changed from an initial configuration to a deflected configuration by tensioning a suture which is connected with a central portion of the anchor. Since the embodiment of the invention illustrated in FIG. 14 is generally similar to the embodiment of the invention illustrated in FIG. 13, similar numerals will be utilized to designate similar components, the suffix letter “j” being associated with the numerals of FIG. 14 to avoid confusion.


An anchor 20j has an outer side surface 26j. The outer side surface 26j extends between opposite end surfaces 36j and 40j of the anchor.


A suture 32j is connected with a central portion of the anchor 20j disposed between the opposite end surfaces 36j and 40j. The anchor 20j is formed of the same hydrophilic polymeric material as the anchor 20 of FIGS. 1-3. The anchor 20j is inserted into body tissue 22j in the same manner as described in connection with the embodiment of the invention illustrated FIG. 13.


Prior to insertion of the anchor 20j into the body tissue 22j, the anchor 20j has a solid cylindrical configuration with a straight longitudinal central axis. As the anchor 20j is inserted into the body tissue 22j and moved to the orientation shown in FIG. 14, the suture 32j is tensioned. Tensioning of the suture 32j presses the outer side surface 26j of the anchor 20j against the body tissue 22j. As this occurs, the anchor 20j is deflected from its initial configuration to the deflected configuration illustrated in FIG. 14. When the anchor 20j is in the deflected orientation, the longitudinal central axis of the anchor has an arcuate configuration.

Claims
  • 1. An anchor for securing a suture relative to bone comprising: a generally cylindrical body portion having an exterior surface, a leading end configured to facilitate insertion of the body portion into the bone, a trailing end opposite the leading end, and a generally cylindrical opening extending from the trailing end toward the leading end, the generally cylindrical opening having a central axis, the body portion having a length and a central longitudinal axis extending from the leading end to the trailing end, the generally cylindrical opening having a length that is greater than a majority of the length of the body portion, the central axis of the generally cylindrical opening being coaxial with the central longitudinal axis of the body portion;a passage located proximate the leading end of the body portion for receipt of the suture, the passage having a central axis, the central axis of the passage being oriented transverse to and intersecting both the central longitudinal axis of the body portion and the central axis of the generally cylindrical opening, the anchor being formed of at least two different materials suitable for implantation in bone, a first of the at least two different materials forming a perimeter around the generally cylindrical opening, a second of the at least two different materials forming the leading end; andbone engaging projections configured to secure the anchor in the bone,wherein the anchor is structured to permit the suture to be positioned along a majority of the length of the exterior surface of the body portion to secure the suture between the bone and the anchor when the anchor is implanted in the bone.
  • 2. The anchor of claim 1, wherein the trailing end includes a generally flat annular surface transverse to the central longitudinal axis of the body portion.
  • 3. The anchor of claim 1, wherein a cross-section of the suture passage has an uninterrupted perimeter.
  • 4. The anchor of claim 1, wherein the opening is configured to permit at least a portion of a suture to be disposed therein.
  • 5. The anchor of claim 1, wherein the leading end of the body portion is at least in part conical.
  • 6. The anchor of claim 1, further comprising a pointed tip to facilitate piercing the bone.
  • 7. The anchor of claim 1, wherein at least one of the at least two different materials is a polymeric material.
  • 8. The anchor of claim 7, wherein the polymeric material is a copolymer.
  • 9. The anchor of claim 7, wherein the polymeric material is a dipolymer.
  • 10. The anchor of claim 7, wherein the polymeric material is one selected from the group consisting of cellulose, petroglutamic acid, high purity carboxymethylcellulose, a collagen, and a polylactide.
  • 11. The anchor of claim 1, wherein the trailing end is configured to be engaged by a driver.
  • 12. The anchor of claim 1, wherein the body portion is implantable in soft tissue.
  • 13. The anchor of claim 1, wherein the bone engaging projections comprise ribs projecting radially from the exterior surface of the cylindrical body portion.
RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 11/230,020 filed Sep. 19, 2005; which is a continuation of U.S. application Ser. No. 10/442,353 filed May 21, 2003 (now U.S. Pat. No. 6,955,683). The aforementioned '353 application is itself a continuation of U.S. application Ser. No. 09/703,058 filed Oct. 31, 2000 (now U.S. Pat. No. 6,572,635). The aforementioned '058 application is itself a continuation of U.S. application Ser. No. 09/378,190 filed Aug. 20, 1999 (now U.S. Pat. No. 6,152,949). The aforementioned '190 application is itself a continuation of U.S. application Ser. No. 08/964,167 filed Nov. 4, 1997 (now U.S. Pat. No. 5,980,559). The aforementioned '167 application is itself a divisional of U.S. application Ser. No. 08/699,553 filed Aug. 19, 1996 (now U.S. Pat. No. 5,718,717). The benefit of the earlier filing dates of the aforementioned applications is hereby claimed.

US Referenced Citations (1232)
Number Name Date Kind
157343 Molesworth Dec 1874 A
319296 Molesworth Jun 1885 A
668878 Jensen Feb 1901 A
668879 Miller Feb 1901 A
673783 Peters May 1901 A
702789 Gibson Jun 1902 A
832201 Kistler Oct 1906 A
862712 Collins Aug 1907 A
1213005 Pillsbury Jan 1917 A
1433031 Henri Oct 1922 A
1725670 William Aug 1929 A
1863057 Innes Jun 1932 A
1870942 Beatty Aug 1932 A
2121193 Hanicke Dec 1932 A
1909967 Jones May 1933 A
1959615 Derrah May 1934 A
2187852 Friddle Aug 1936 A
2178840 Lorenian Nov 1936 A
2199025 Conn Apr 1940 A
2235419 Callahan Mar 1941 A
2248054 Becker Jul 1941 A
2270188 Longfellow Jan 1942 A
2433815 Nicephore et al. Dec 1947 A
2518276 Brawand Aug 1950 A
2526662 Hipps et al. Oct 1950 A
2557669 Lloyd Jun 1951 A
2566499 Richter Sep 1951 A
2589720 Marl Mar 1952 A
2621145 Sano Dec 1952 A
2621653 Briggs Dec 1952 A
2642874 Keeling Jun 1953 A
2687719 William Aug 1954 A
2701559 Cooper Feb 1955 A
2724326 Long Nov 1955 A
2725053 Bambara Nov 1955 A
2830587 Everett Apr 1958 A
2854983 Baskin Oct 1958 A
2936760 Gants May 1960 A
2955530 Nilo Oct 1960 A
3039468 Price Jun 1962 A
3048522 Velley Aug 1962 A
3081773 Boyd Mar 1963 A
3108357 Liebig Oct 1963 A
3108595 Overment Oct 1963 A
3204635 Voss et al. Sep 1965 A
3229006 Egon Jan 1966 A
3253594 Matthews et al. May 1966 A
3347234 Voss Oct 1967 A
3367809 Soloff Feb 1968 A
3391690 Armao Jul 1968 A
3397699 Kohl Aug 1968 A
3417745 Emanuel Dec 1968 A
3459175 Miller Aug 1969 A
3469003 Hardy Sep 1969 A
3477429 Sampson Nov 1969 A
3495586 Regenbogen Feb 1970 A
3513848 Winston et al. May 1970 A
3514791 Sparks Jun 1970 A
3517128 Hines Jun 1970 A
3518993 Blake Jul 1970 A
3554192 Isberner Jan 1971 A
3557794 Patten Jan 1971 A
3577991 Wilkinson May 1971 A
3593709 Halloran Jul 1971 A
3596292 Erb et al. Aug 1971 A
3608539 Miller Sep 1971 A
3613497 Heldermann Oct 1971 A
3620218 Schmitt et al. Nov 1971 A
3624747 McKnight et al. Nov 1971 A
3625220 Engelsher Dec 1971 A
3626949 Shute Dec 1971 A
3635223 Klieman Jan 1972 A
3648705 Lary Mar 1972 A
3653388 Tenckhoff Apr 1972 A
3656476 Swinney Apr 1972 A
3657056 Winston et al. Apr 1972 A
3670732 Robinson Jun 1972 A
3678980 Gutshall Jul 1972 A
3698017 Scales et al. Oct 1972 A
3709218 Halloran Jan 1973 A
3711347 Wagner et al. Jan 1973 A
3716051 Fischer Feb 1973 A
3721244 Elmaleh Mar 1973 A
3739773 Schmitt et al. Jun 1973 A
3750652 Sherwin Aug 1973 A
3760808 Bleuer Sep 1973 A
3769980 Karman Nov 1973 A
3774244 Walker Nov 1973 A
3774596 Cook Nov 1973 A
3779239 Fischer et al. Dec 1973 A
3788318 Kim et al. Jan 1974 A
3789852 Kim et al. Feb 1974 A
3800788 White Apr 1974 A
3802438 Wolvek Apr 1974 A
3804089 Bridgman Apr 1974 A
3807393 McDonald Apr 1974 A
3807394 Attenborough Apr 1974 A
3809075 Matles May 1974 A
3811449 Gravlee et al. May 1974 A
3812855 Banko May 1974 A
3825010 McDonald Jul 1974 A
3833003 Taricco Sep 1974 A
3835849 McGuire Sep 1974 A
3841304 Jones Oct 1974 A
3842824 Neufeld Oct 1974 A
3845772 Smith Nov 1974 A
3850172 Cazalis Nov 1974 A
3850720 Collins Nov 1974 A
3852830 Marmor Dec 1974 A
3857396 Hardwick Dec 1974 A
3863639 Kleaveland Feb 1975 A
3867932 Huene Feb 1975 A
3869731 Waugh et al. Mar 1975 A
3874264 Polos Apr 1975 A
3875652 Arnold Apr 1975 A
3875946 Duncan Apr 1975 A
3882852 Sinnreich May 1975 A
3889686 Duturbure et al. Jun 1975 A
3894530 Dardik et al. Jul 1975 A
3898992 Balamuth Aug 1975 A
3903549 Deyerle Sep 1975 A
3911923 Yoon Oct 1975 A
3915171 Shermeta Oct 1975 A
3918442 Nikolaev et al. Nov 1975 A
3920022 Pastor Nov 1975 A
3939835 Bridgman Feb 1976 A
3945375 Banko Mar 1976 A
3960143 Terada Jun 1976 A
3961632 Moossun Jun 1976 A
3967625 Yoon Jul 1976 A
3968800 Vilasi Jul 1976 A
3970089 Saice Jul 1976 A
3973277 Semple et al. Aug 1976 A
3976079 Samuels et al. Aug 1976 A
3989049 Yoon Nov 1976 A
3991426 Flom et al. Nov 1976 A
3994287 Turp et al. Nov 1976 A
4000525 Klawitter et al. Jan 1977 A
4022216 Stevens May 1977 A
4023559 Gaskell May 1977 A
4040413 Ohshiro Aug 1977 A
4053953 Flom et al. Oct 1977 A
4055862 Farling Nov 1977 A
4064566 Fletcher et al. Dec 1977 A
4077412 Moossun Mar 1978 A
4081866 Upshaw et al. Apr 1978 A
4083369 Sinnreich Apr 1978 A
4085466 Goodfellow et al. Apr 1978 A
4085743 Yoon Apr 1978 A
4089071 Kainberz et al. May 1978 A
4092113 Hardy May 1978 A
4103680 Yoon Aug 1978 A
RE29757 Helfet Sep 1978 E
4122605 Hirabay et al. Oct 1978 A
4142517 Contreras et al. Mar 1979 A
4148307 Utsugi Apr 1979 A
4156574 Boben May 1979 A
4164794 Spector et al. Aug 1979 A
4169470 Ender et al. Oct 1979 A
4171544 Hench et al. Oct 1979 A
4177814 Knepshield et al. Dec 1979 A
4183102 Guiset Jan 1980 A
4186448 Brekke Feb 1980 A
4191747 Scheicher Mar 1980 A
4198981 Sinnreich Apr 1980 A
4199864 Ashman Apr 1980 A
4200939 Oser May 1980 A
4203444 Bonnell et al. May 1980 A
4209012 Smucker Jun 1980 A
4209861 Borzone et al. Jul 1980 A
4210148 Stivala Jul 1980 A
4210580 Amrani Jul 1980 A
4213209 Insall et al. Jul 1980 A
4213816 Morris Jul 1980 A
4224696 Murray et al. Sep 1980 A
4224929 Furihata Sep 1980 A
4228802 Trott Oct 1980 A
4230119 Blum Oct 1980 A
4235233 Mouwen Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4240433 Bordow Dec 1980 A
4243048 Griffin Jan 1981 A
4244370 Furlow et al. Jan 1981 A
4257411 Cho Mar 1981 A
4263900 Nicholson Apr 1981 A
4265231 Scheller, Jr. et al. May 1981 A
4265848 Ruesch May 1981 A
4274414 Johnson et al. Jun 1981 A
4281649 Derweduwen Aug 1981 A
4291698 Fuchs Sep 1981 A
4295464 Shihata Oct 1981 A
4298002 Ronel et al. Nov 1981 A
4298992 Burstein et al. Nov 1981 A
4298998 Naficy Nov 1981 A
4299224 Noiles Nov 1981 A
4299227 Lincoff Nov 1981 A
4304178 Haeberle Dec 1981 A
4309488 Heide et al. Jan 1982 A
4311145 Esty et al. Jan 1982 A
4312353 Shahbabian Jan 1982 A
4320762 Bentov Mar 1982 A
4344193 Kenny Aug 1982 A
4349029 Mott Sep 1982 A
4349921 Kuntz Sep 1982 A
4351069 Ballintyn et al. Sep 1982 A
4352883 Lim Oct 1982 A
4357940 Muller Nov 1982 A
4364381 Sher et al. Dec 1982 A
4365356 Broemer et al. Dec 1982 A
4369768 Vukovic Jan 1983 A
4373217 Draenert Feb 1983 A
4373709 Whitt Feb 1983 A
4374523 Yoon Feb 1983 A
4385404 Sully et al. May 1983 A
4388921 Sutter et al. Jun 1983 A
4391909 Lim Jul 1983 A
4395798 Mc Vey Aug 1983 A
4400833 Kurland Aug 1983 A
4407273 Ouchi Oct 1983 A
4409974 Freedland Oct 1983 A
4414166 Charlson et al. Nov 1983 A
4421112 Mains et al. Dec 1983 A
4430760 Smestad Feb 1984 A
4434797 Silander Mar 1984 A
4437191 Van der Zat et al. Mar 1984 A
4437362 Hurst Mar 1984 A
4442655 Stroetmann et al. Apr 1984 A
4444180 Schneider et al. Apr 1984 A
4445509 Auth May 1984 A
4447227 Kotsanis May 1984 A
4448194 DiGiovanni et al. May 1984 A
4450591 Rappaport May 1984 A
4453421 Umano Jun 1984 A
4453539 Raftopoulos et al. Jun 1984 A
4456005 Lichty Jun 1984 A
4457302 Caspari et al. Jul 1984 A
4461281 Carson Jul 1984 A
4466429 Loscher et al. Aug 1984 A
4466888 Verkaart Aug 1984 A
4472840 Jefferies Sep 1984 A
4474177 Whiteside Oct 1984 A
4484579 Meno et al. Nov 1984 A
4485096 Bell Nov 1984 A
4487203 Androphy Dec 1984 A
4493317 Klaue Jan 1985 A
4495664 Bianquaert Jan 1985 A
4501031 McDaniel et al. Feb 1985 A
4501266 McDaniel Feb 1985 A
4501269 Bagby Feb 1985 A
4502159 Woodroof et al. Mar 1985 A
4502161 Wall Mar 1985 A
4504268 Herlitze Mar 1985 A
4505274 Speelman Mar 1985 A
4506681 Mundell Mar 1985 A
4509518 McGarry et al. Apr 1985 A
4514125 Stol Apr 1985 A
4516276 Mittelmeier et al. May 1985 A
4526173 Sheehan Jul 1985 A
4532926 O'Halla Aug 1985 A
4535757 Webster Aug 1985 A
4535772 Sheehan Aug 1985 A
4540404 Wolvek Sep 1985 A
4541423 Barber Sep 1985 A
4545374 Jacobson Oct 1985 A
4545375 Cline Oct 1985 A
4547327 Bruins et al. Oct 1985 A
4551135 Gorman et al. Nov 1985 A
4553272 Mears Nov 1985 A
4554686 Baker Nov 1985 A
4555242 Saudagar Nov 1985 A
4556059 Adamson, Jr. Dec 1985 A
4556350 Bernhardt et al. Dec 1985 A
4556391 Tardivel et al. Dec 1985 A
4562598 Kranz Jan 1986 A
4565192 Shapiro Jan 1986 A
4566138 Lewis et al. Jan 1986 A
4572186 Gould et al. Feb 1986 A
4573448 Kambin Mar 1986 A
4574794 Cooke et al. Mar 1986 A
4575371 Nordqvist et al. Mar 1986 A
4584722 Levy Apr 1986 A
4585000 Hershenson Apr 1986 A
4589414 Yoshida et al. May 1986 A
4589686 McGrew May 1986 A
4589868 Dretler May 1986 A
4590928 Hunt et al. May 1986 A
4597379 Kihn et al. Jul 1986 A
4599085 Riess et al. Jul 1986 A
4601893 Cardinal Jul 1986 A
4603694 Wheeler Aug 1986 A
4606335 Wedeen Aug 1986 A
4608052 Van Kampen et al. Aug 1986 A
4608965 Anspach, Jr. et al. Sep 1986 A
4610662 Weikl et al. Sep 1986 A
4611593 Fogarty et al. Sep 1986 A
4615717 Neubauer et al. Oct 1986 A
4619391 Sharkany et al. Oct 1986 A
4621640 Mulhollan et al. Nov 1986 A
4623553 Ries et al. Nov 1986 A
4624254 McGarry et al. Nov 1986 A
4630609 Chin Dec 1986 A
4632101 Freedland Dec 1986 A
4641648 Shapiro Feb 1987 A
4642117 Nguyen et al. Feb 1987 A
4642120 Nevo et al. Feb 1987 A
4645503 Lin et al. Feb 1987 A
4646736 Auth Mar 1987 A
4646738 Trott Mar 1987 A
4649918 Pegg et al. Mar 1987 A
4651717 Jakubczak Mar 1987 A
4651752 Fuerst Mar 1987 A
4654464 Mittelmeier et al. Mar 1987 A
4657460 Bien Apr 1987 A
4657548 Nichols Apr 1987 A
4659268 Del Mundo et al. Apr 1987 A
4662063 Collins et al. May 1987 A
4662068 Polonsky May 1987 A
4662372 Sharkany et al. May 1987 A
4662887 Turner et al. May 1987 A
4669473 Richards et al. Jun 1987 A
4678470 Nashef et al. Jul 1987 A
4681106 Kensey et al. Jul 1987 A
4681107 Kees, Jr. Jul 1987 A
4682598 Beraha Jul 1987 A
4685458 Leckrone Aug 1987 A
4685460 Thornton Aug 1987 A
4691741 Affa et al. Sep 1987 A
4696667 Masch Sep 1987 A
4705040 Mueller et al. Nov 1987 A
4706659 Matthews et al. Nov 1987 A
4706670 Andersen et al. Nov 1987 A
4708139 Dunbar, IV Nov 1987 A
4711233 Brown Dec 1987 A
4712542 Daniel Dec 1987 A
4713076 Draenert Dec 1987 A
4713077 Small Dec 1987 A
4714074 Rey et al. Dec 1987 A
4716893 Fischer et al. Jan 1988 A
4716901 Jackson et al. Jan 1988 A
4718909 Brown Jan 1988 A
4718916 Morscher Jan 1988 A
4719908 Averill et al. Jan 1988 A
4721096 Naughton et al. Jan 1988 A
4721103 Freedland Jan 1988 A
4721104 Kaufman et al. Jan 1988 A
4722331 Fox Feb 1988 A
4722948 Sanderson Feb 1988 A
4724584 Kasai Feb 1988 A
4738255 Goble et al. Apr 1988 A
4739751 Sapega et al. Apr 1988 A
4741330 Hayhurst May 1988 A
4743229 Chu May 1988 A
4743259 Bolander et al. May 1988 A
4744364 Kensey May 1988 A
4747405 Leckrone May 1988 A
4749585 Greco et al. Jun 1988 A
4750488 Wuchinich et al. Jun 1988 A
4750492 Jacobs Jun 1988 A
4751922 DiPietropolo Jun 1988 A
4755184 Silverberg Jul 1988 A
4759350 Dunn et al. Jul 1988 A
4768507 Fischell et al. Sep 1988 A
4772286 Goble et al. Sep 1988 A
4776328 Frey et al. Oct 1988 A
4776738 Winston Oct 1988 A
4776851 Bruchman et al. Oct 1988 A
4779611 Grooters et al. Oct 1988 A
4781182 Purnell et al. Nov 1988 A
4781681 Sharrow et al. Nov 1988 A
4781922 Bone Nov 1988 A
4784133 Mackin Nov 1988 A
4789663 Wallace et al. Dec 1988 A
4790303 Steffee Dec 1988 A
4790819 Li et al. Dec 1988 A
4792336 Hiavacek et al. Dec 1988 A
4793359 Sharrow Dec 1988 A
4794854 Swaim Jan 1989 A
4795467 Piez et al. Jan 1989 A
4796629 Grayzel Jan 1989 A
4798205 Bonomo et al. Jan 1989 A
4798213 Doppelt Jan 1989 A
4800901 Rosenberg Jan 1989 A
4801299 Brendel et al. Jan 1989 A
4802479 Haber et al. Feb 1989 A
4817591 Klause Apr 1989 A
4817602 Beraha Apr 1989 A
4822224 Carl et al. Apr 1989 A
4823794 Pierce Apr 1989 A
4825857 Kenna May 1989 A
4828563 Mueller et al. May 1989 A
4832025 Coates May 1989 A
4832026 Jones May 1989 A
4832683 Idemoto et al. May 1989 A
4834752 Van Kampen May 1989 A
4834757 Brantigan May 1989 A
4841960 Garner Jun 1989 A
4842517 Kawahara et al. Jun 1989 A
4843112 Gerhart Jun 1989 A
4844064 Thimsen et al. Jul 1989 A
4846791 Hattler et al. Jul 1989 A
4846812 Walker et al. Jul 1989 A
4846835 Grande Jul 1989 A
4857045 Rydell Aug 1989 A
4861334 Nawaz Aug 1989 A
4862874 Kellner Sep 1989 A
4862882 Venturi et al. Sep 1989 A
4862974 Warren et al. Sep 1989 A
4863472 Tormala et al. Sep 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4869242 Galluzzo Sep 1989 A
4870957 Goble et al. Oct 1989 A
4875468 Krauter et al. Oct 1989 A
4877020 Vich Oct 1989 A
4880429 Stone Nov 1989 A
4883048 Purnell et al. Nov 1989 A
4883666 Sabel et al. Nov 1989 A
4888022 Huebsch Dec 1989 A
4890612 Kensey Jan 1990 A
4892552 Ainsworth et al. Jan 1990 A
4895148 Bays et al. Jan 1990 A
4898156 Gatturna et al. Feb 1990 A
4899729 Gill et al. Feb 1990 A
4899743 Nicholson et al. Feb 1990 A
4899744 Fujitsuka et al. Feb 1990 A
4901721 Hakki Feb 1990 A
4902296 Bolander et al. Feb 1990 A
4904259 Itay Feb 1990 A
4904261 Dove Feb 1990 A
4909789 Taguchi Mar 1990 A
4911721 Aendergaten et al. Mar 1990 A
4919667 Richmond Apr 1990 A
4921478 Solano et al. May 1990 A
4921479 Grayzel May 1990 A
4922897 Sapega et al. May 1990 A
4923464 Dipisa, Jr. May 1990 A
4924865 Bays et al. May 1990 A
4924866 Yoon May 1990 A
4927412 Menasche May 1990 A
4927421 Goble et al. May 1990 A
4932956 Reddy et al. Jun 1990 A
4932959 Horzewski et al. Jun 1990 A
4932960 Green et al. Jun 1990 A
4932973 Gendler Jun 1990 A
4935023 Whiteside et al. Jun 1990 A
4935028 Drews Jun 1990 A
4936848 Bagby Jun 1990 A
4936852 Kent et al. Jun 1990 A
4944760 Kenna Jul 1990 A
4945625 Winston Aug 1990 A
4945896 Gade Aug 1990 A
4946468 Li Aug 1990 A
4950296 McIntyre Aug 1990 A
4950298 Gustilo et al. Aug 1990 A
4952213 Bowman et al. Aug 1990 A
4954126 Wallsten Sep 1990 A
4955910 Bolesky Sep 1990 A
4957498 Caspari et al. Sep 1990 A
4961740 Ray et al. Oct 1990 A
4961741 Hayhurst Oct 1990 A
4961954 Goldberg et al. Oct 1990 A
4963151 Ducheyne et al. Oct 1990 A
4963489 Naughton et al. Oct 1990 A
4964862 Arms Oct 1990 A
4964865 Burkhead et al. Oct 1990 A
4966583 Debbas Oct 1990 A
4968298 Michelson Nov 1990 A
4968315 Gatturna Nov 1990 A
4969888 Scholten et al. Nov 1990 A
4969892 Burton et al. Nov 1990 A
4969895 McLeod et al. Nov 1990 A
4979949 Matsen, III et al. Dec 1990 A
4979957 Hodorek Dec 1990 A
4983179 Sjostrom Jan 1991 A
4984563 Renaud Jan 1991 A
4984564 Yuen Jan 1991 A
4985038 Lyell Jan 1991 A
4990161 Kampner Feb 1991 A
4994047 Walker et al. Feb 1991 A
4994067 Summers Feb 1991 A
4994071 MacGregor Feb 1991 A
4995868 Brazier Feb 1991 A
4997445 Hodorek Mar 1991 A
4998539 Delsanti Mar 1991 A
5002550 Li Mar 1991 A
5002557 Hasson Mar 1991 A
5002563 Pyka et al. Mar 1991 A
5007912 Albrektsson et al. Apr 1991 A
5009652 Morgan et al. Apr 1991 A
5009662 Wallace et al. Apr 1991 A
5009663 Broome Apr 1991 A
5009664 Sievers Apr 1991 A
5013316 Goble et al. May 1991 A
5015247 Michelson May 1991 A
5015255 Kuslich May 1991 A
5019090 Pinchuk May 1991 A
5019104 Whiteside et al. May 1991 A
5021056 Hofmann et al. Jun 1991 A
5021059 Kensey et al. Jun 1991 A
5026373 Ray et al. Jun 1991 A
5027827 Cody et al. Jul 1991 A
5032132 Matsen, III et al. Jul 1991 A
5035699 Coates Jul 1991 A
5035713 Friis Jul 1991 A
5037404 Gold et al. Aug 1991 A
5037422 Hayhurst et al. Aug 1991 A
5037423 Kenna Aug 1991 A
5041093 Chu Aug 1991 A
5041114 Chapman et al. Aug 1991 A
5041125 Montano Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5042976 Ishitsu et al. Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047055 Bao et al. Sep 1991 A
5051049 Wills Sep 1991 A
5053009 Herzberg Oct 1991 A
5053039 Hofmann et al. Oct 1991 A
5053046 Janese Oct 1991 A
5053047 Yoon Oct 1991 A
5059193 Kuslich Oct 1991 A
5059206 Winters Oct 1991 A
5060678 Bauman et al. Oct 1991 A
5061274 Kensey Oct 1991 A
5061281 Mares et al. Oct 1991 A
5061286 Lyle Oct 1991 A
5062843 Mahony Nov 1991 A
5069674 Fearnot et al. Dec 1991 A
5071411 Hillstead Dec 1991 A
5073373 O'Leary et al. Dec 1991 A
5078731 Hayhurst Jan 1992 A
5078744 Chvapil Jan 1992 A
5078745 Rhenter et al. Jan 1992 A
5082670 Gage et al. Jan 1992 A
5084050 Draenert Jan 1992 A
5084051 Tormala et al. Jan 1992 A
5085660 Lin Feb 1992 A
5085661 Moss Feb 1992 A
5092348 Dubrul et al. Mar 1992 A
5098433 Freedland Mar 1992 A
5098434 Serbousek Mar 1992 A
5098436 Ferrante et al. Mar 1992 A
5098437 Kashuba et al. Mar 1992 A
5099859 Bell Mar 1992 A
5100405 Mclaren Mar 1992 A
5100409 Coates et al. Mar 1992 A
5100417 Cerier et al. Mar 1992 A
5100689 Goldberg et al. Mar 1992 A
5101720 Bianchi Apr 1992 A
5102417 Palmaz Apr 1992 A
5102421 Anspach, Jr. Apr 1992 A
5104383 Shichman Apr 1992 A
5108399 Eitenmuller et al. Apr 1992 A
5108433 May et al. Apr 1992 A
5108441 McDowell Apr 1992 A
5111987 Moeinzadeh et al. May 1992 A
5116374 Stone May 1992 A
5120175 Arbegast et al. Jun 1992 A
5122122 Allgood Jun 1992 A
5122144 Bert et al. Jun 1992 A
5123520 Schmid et al. Jun 1992 A
5123906 Kelman Jun 1992 A
5123914 Cope Jun 1992 A
5123941 Lauren et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
RE34021 Mueller Aug 1992 E
5135522 Fahrenkrug et al. Aug 1992 A
5139520 Rosenberg Aug 1992 A
5141520 Goble et al. Aug 1992 A
5143062 Peckham Sep 1992 A
5143093 Sahota Sep 1992 A
5147362 Goble Sep 1992 A
5152744 Krause et al. Oct 1992 A
5152765 Ross et al. Oct 1992 A
5152778 Bales, Jr. et al. Oct 1992 A
5154717 Matsen, III et al. Oct 1992 A
5154720 Trott et al. Oct 1992 A
5156613 Sawyer Oct 1992 A
5156616 Meadows et al. Oct 1992 A
5158553 Berry et al. Oct 1992 A
5158566 Pianetti Oct 1992 A
5158571 Picha Oct 1992 A
5158934 Ammann et al. Oct 1992 A
5159921 Hoover Nov 1992 A
5162506 Hadden Nov 1992 A
5163949 Bonutti Nov 1992 A
5163960 Bonutti Nov 1992 A
5170800 Smith et al. Dec 1992 A
5171243 Kashuba et al. Dec 1992 A
5171244 Caspari et al. Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5171276 Caspari et al. Dec 1992 A
5174300 Bales et al. Dec 1992 A
1312518 Hayhurst Jan 1993 A
5176682 Chow Jan 1993 A
5176684 Ferrante et al. Jan 1993 A
5176702 Bales et al. Jan 1993 A
5178622 Lehner, II Jan 1993 A
5179964 Cook Jan 1993 A
5180388 Di Carlo Jan 1993 A
5183053 Yeh et al. Feb 1993 A
5183464 Dubrul et al. Feb 1993 A
5185001 Galanakis Feb 1993 A
5186178 Yeh et al. Feb 1993 A
5192287 Fournier et al. Mar 1993 A
5192326 Bao et al. Mar 1993 A
5192327 Brantigan Mar 1993 A
5195507 Bilweis Mar 1993 A
5195970 Gahara Mar 1993 A
5197166 Meier et al. Mar 1993 A
5197488 Kovacevic Mar 1993 A
5197955 Stephens et al. Mar 1993 A
5197968 Clement Mar 1993 A
5197971 Bonutti Mar 1993 A
5197987 Koch et al. Mar 1993 A
5201768 Caspari et al. Apr 1993 A
5203784 Ross et al. Apr 1993 A
5203787 Noblitt et al. Apr 1993 A
5204106 Schepers et al. Apr 1993 A
5207692 Kraus et al. May 1993 A
5208950 Merritt May 1993 A
5209776 Bass et al. May 1993 A
5211647 Schmieding May 1993 A
5217463 Mikhail Jun 1993 A
5217486 Rice et al. Jun 1993 A
5217493 Raad et al. Jun 1993 A
5219359 McQuilkin et al. Jun 1993 A
5224946 Hayhurst et al. Jul 1993 A
5226426 Yoon Jul 1993 A
5226877 Epstein Jul 1993 A
5226899 Lee et al. Jul 1993 A
5226915 Bertin Jul 1993 A
5228459 Caspari et al. Jul 1993 A
5234006 Eaton et al. Aug 1993 A
5234425 Fogarty et al. Aug 1993 A
5234433 Bert et al. Aug 1993 A
5236432 Matsen, III et al. Aug 1993 A
5236438 Wilk Aug 1993 A
5236445 Hayhurst et al. Aug 1993 A
5242902 Murphy et al. Sep 1993 A
5244946 Guest et al. Sep 1993 A
5246441 Ross et al. Sep 1993 A
5250026 Ehrlich et al. Oct 1993 A
5250055 Moore et al. Oct 1993 A
5250070 Parodi Oct 1993 A
5254091 Aliahmad et al. Oct 1993 A
5254113 Wilk Oct 1993 A
5258004 Bales et al. Nov 1993 A
5258007 Spetzler et al. Nov 1993 A
5258015 Li et al. Nov 1993 A
5258016 DiPoto et al. Nov 1993 A
5258031 Salib et al. Nov 1993 A
5258032 Bertin Nov 1993 A
5261914 Warren Nov 1993 A
5263498 Caspari et al. Nov 1993 A
5263987 Shah Nov 1993 A
5266325 Kuzma et al. Nov 1993 A
5268001 Nicholson et al. Dec 1993 A
5269783 Sander Dec 1993 A
5269785 Bonutti Dec 1993 A
5269809 Hayhurst et al. Dec 1993 A
5273524 Fox et al. Dec 1993 A
5275166 Vaitekunas et al. Jan 1994 A
5281235 Haber et al. Jan 1994 A
5282803 Lackey Feb 1994 A
5282832 Toso et al. Feb 1994 A
5282861 Kaplan Feb 1994 A
5284655 Bogdansky et al. Feb 1994 A
5285655 Sung-II et al. Feb 1994 A
5290249 Foster et al. Mar 1994 A
5290281 Tschakaloff Mar 1994 A
5295994 Bonutti Mar 1994 A
5298254 Prewett et al. Mar 1994 A
2696338 Perrin Apr 1994 A
5304119 Balaban et al. Apr 1994 A
5304181 Caspari et al. Apr 1994 A
5306280 Bregen et al. Apr 1994 A
5306301 Graf et al. Apr 1994 A
5312438 Johnson May 1994 A
5315741 Dubberke May 1994 A
5318588 Horzewski et al. Jun 1994 A
5320611 Bonutti Jun 1994 A
5322505 Krause et al. Jun 1994 A
5324308 Pierce Jun 1994 A
5326361 Hollister Jul 1994 A
5328480 Melker et al. Jul 1994 A
5329846 Bonutti Jul 1994 A
5329924 Bonutti Jul 1994 A
5330468 Burkhart Jul 1994 A
5330476 Hiot et al. Jul 1994 A
5330486 Wilk Jul 1994 A
5330497 Freitas et al. Jul 1994 A
5331975 Bonutti Jul 1994 A
5334146 Ozasa Aug 1994 A
5336231 Adair Aug 1994 A
5336240 Metzler et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5345927 Bonutti Sep 1994 A
5349956 Bonutti Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354298 Lee et al. Oct 1994 A
5354302 Ko Oct 1994 A
5356413 Martins et al. Oct 1994 A
5360450 Giannini Nov 1994 A
5366480 Corriveau et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370660 Weinstein et al. Dec 1994 A
5370662 Stone et al. Dec 1994 A
5372146 Branch Dec 1994 A
5374235 Ahrens Dec 1994 A
5376101 Green et al. Dec 1994 A
5376126 Lin Dec 1994 A
5379759 Sewell, Jr. Jan 1995 A
5382254 McGarry et al. Jan 1995 A
5383883 Wilk et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5383937 Mikhail Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5390683 Pisharodi Feb 1995 A
5391171 Schmieding Feb 1995 A
5391173 Wilk Feb 1995 A
RE34871 McGuire et al. Mar 1995 E
5395308 Fox et al. Mar 1995 A
5395376 Caspari et al. Mar 1995 A
5397311 Walker et al. Mar 1995 A
5397331 Himpens et al. Mar 1995 A
5400805 Warren Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403317 Bonutti Apr 1995 A
5403348 Bonutti Apr 1995 A
5405359 Pierce Apr 1995 A
5411523 Goble May 1995 A
5413585 Pagedas May 1995 A
5415663 Luckman et al. May 1995 A
5417691 Hayhurst May 1995 A
5417700 Egan May 1995 A
5417701 Holmes May 1995 A
5417712 Whittaker et al. May 1995 A
5423796 Shikhman et al. Jun 1995 A
5423819 Small et al. Jun 1995 A
5423860 Lizardi et al. Jun 1995 A
5425733 Schmieding Jun 1995 A
5431670 Holmes Jul 1995 A
5439470 Li et al. Aug 1995 A
5441502 Bartlett Aug 1995 A
5441538 Bonutti Aug 1995 A
5443482 Stone et al. Aug 1995 A
5443512 Parr et al. Aug 1995 A
5445615 Yoon Aug 1995 A
5447503 Miller Sep 1995 A
5449372 Schmaltz et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5451235 Lock Sep 1995 A
5453090 Martinez et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5456722 Mcleod et al. Oct 1995 A
5458653 Davison Oct 1995 A
5462549 Glock Oct 1995 A
5462561 Voda Oct 1995 A
5464424 O'Donnell, Jr. Nov 1995 A
5464425 Skiba Nov 1995 A
5464426 Bonutti Nov 1995 A
5464427 Curtis et al. Nov 1995 A
5470337 Moss Nov 1995 A
5472444 Huebner et al. Dec 1995 A
5474554 Ku Dec 1995 A
5474559 Bertin et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5480403 Lee et al. Jan 1996 A
5484437 Michelson Jan 1996 A
5486197 Le et al. Jan 1996 A
5487844 Fujita Jan 1996 A
5488958 Topel et al. Feb 1996 A
5492697 Boyan et al. Feb 1996 A
5496292 Burnham Mar 1996 A
5496335 Thomason et al. Mar 1996 A
5496348 Bonutti Mar 1996 A
5500000 Feagin et al. Mar 1996 A
5501700 Hirata Mar 1996 A
5504977 Weppner Apr 1996 A
5505735 Li Apr 1996 A
5507754 Green et al. Apr 1996 A
5514091 Yoon May 1996 A
5514153 Bonutti May 1996 A
5520700 Beyar et al. May 1996 A
5522844 Johnson Jun 1996 A
5522845 Wenstrom, Jr. Jun 1996 A
5522846 Bonutti Jun 1996 A
5527341 Gogolewski et al. Jun 1996 A
5527342 Pietrzak et al. Jun 1996 A
5527343 Bonutti Jun 1996 A
5529075 Clark Jun 1996 A
5531759 Kensey et al. Jul 1996 A
5534012 Bonutti Jul 1996 A
5534028 Bao et al. Jul 1996 A
5540718 Bartlett Jul 1996 A
5542423 Bonutti Aug 1996 A
5542947 Treacy Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5545206 Carson Aug 1996 A
5545222 Bonutti Aug 1996 A
5549630 Bonutti Aug 1996 A
5549631 Bonutti Aug 1996 A
5549689 Epstein et al. Aug 1996 A
5550172 Regula et al. Aug 1996 A
2215943 Collette Sep 1996 A
5556402 Xu Sep 1996 A
5562668 Johnson Oct 1996 A
5562684 Kammerer Oct 1996 A
5562688 Riza Oct 1996 A
5569252 Justin et al. Oct 1996 A
5569259 Ferrante et al. Oct 1996 A
5569305 Bonutti Oct 1996 A
5569306 Thal Oct 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5571196 Stein Nov 1996 A
5573517 Bonutti et al. Nov 1996 A
5573538 Laboureau Nov 1996 A
5573542 Stevens Nov 1996 A
5575801 Habermeyer Nov 1996 A
5577517 Bonutti Nov 1996 A
5580344 Hasson Dec 1996 A
5584835 Greenfield Dec 1996 A
5584860 Goble et al. Dec 1996 A
5584862 Bonutti Dec 1996 A
5591206 Moufarrege Jan 1997 A
5593422 Muijs Van De Moer et al. Jan 1997 A
5593425 Bonutti et al. Jan 1997 A
5593625 Riebel et al. Jan 1997 A
5601557 Hayhurst Feb 1997 A
5601558 Torrie et al. Feb 1997 A
5601565 Huebner et al. Feb 1997 A
5601595 Smith Feb 1997 A
5607427 Tschakaloff Mar 1997 A
5609595 Pennig Mar 1997 A
5609635 Michelson Mar 1997 A
5618314 Harwin et al. Apr 1997 A
5620448 Puddu Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5624462 Bonutti Apr 1997 A
5624463 Stone et al. Apr 1997 A
5626612 Bartlett May 1997 A
5626614 Hart May 1997 A
5626718 Philippe et al. May 1997 A
5628751 Sander et al. May 1997 A
5630824 Hart May 1997 A
5634926 Jobe Jun 1997 A
5643274 Sander et al. Jul 1997 A
5643293 Kogasaka et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643320 Lower et al. Jul 1997 A
5643321 McDevitt Jul 1997 A
5644002 Cooper et al. Jul 1997 A
5645553 Kolesa et al. Jul 1997 A
5645588 Graf et al. Jul 1997 A
5645597 Krapiva Jul 1997 A
5645599 Samani Jul 1997 A
5649955 Hashimoto et al. Jul 1997 A
5649963 McDevitt Jul 1997 A
5651377 O'Donnell, Jr. Jul 1997 A
5658313 Thal Aug 1997 A
5660225 Saffran Aug 1997 A
5662658 Wenstrom, Jr. Sep 1997 A
5662710 Bonutti Sep 1997 A
5665089 Dall et al. Sep 1997 A
5665109 Yoon Sep 1997 A
5665112 Thal Sep 1997 A
5667513 Torrie et al. Sep 1997 A
5667520 Bonutti Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5674240 Bonutti Oct 1997 A
5681310 Yuan et al. Oct 1997 A
5681333 Burkhart et al. Oct 1997 A
5681351 Jamiolkowski et al. Oct 1997 A
5681352 Clancy, III et al. Oct 1997 A
5682886 Delp et al. Nov 1997 A
5683401 Schmieding et al. Nov 1997 A
5683418 Luscombe et al. Nov 1997 A
5683469 Johnson et al. Nov 1997 A
5685820 Riek et al. Nov 1997 A
5685826 Bonutti Nov 1997 A
5688283 Knapp Nov 1997 A
5690654 Ovil Nov 1997 A
5690655 Hart et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5690676 DiPoto et al. Nov 1997 A
5693055 Zahiri et al. Dec 1997 A
5694951 Bonutti Dec 1997 A
5697950 Fucci et al. Dec 1997 A
5702397 Goble et al. Dec 1997 A
5702462 Oberlander Dec 1997 A
5707390 Bonutti Jan 1998 A
5707395 Li Jan 1998 A
5713897 Goble Feb 1998 A
5713903 Sander et al. Feb 1998 A
5713921 Bonutti Feb 1998 A
5715836 Kliegis et al. Feb 1998 A
5716325 Bonutti Feb 1998 A
5718717 Bonutti Feb 1998 A
5720747 Burke Feb 1998 A
5720753 Sander et al. Feb 1998 A
5722978 Jenkins, Jr. Mar 1998 A
5723016 Minns et al. Mar 1998 A
5725529 Nicholson et al. Mar 1998 A
5725541 Anspach, III et al. Mar 1998 A
5725556 Moser et al. Mar 1998 A
5725557 Gatturna et al. Mar 1998 A
5725582 Bevan Mar 1998 A
5730747 Ek et al. Mar 1998 A
5733306 Bonutti Mar 1998 A
5735875 Bonutti et al. Apr 1998 A
5735877 Pagedas Apr 1998 A
5735899 Schwartz et al. Apr 1998 A
5741268 Shutz Apr 1998 A
5741282 Anspach, III et al. Apr 1998 A
5752952 Adamson May 1998 A
5752974 Rhee et al. May 1998 A
5755809 Cohen et al. May 1998 A
5762458 Wang et al. Jun 1998 A
5763416 Bonadio et al. Jun 1998 A
5766221 Benderev et al. Jun 1998 A
5766251 Koshino Jun 1998 A
5769854 Bastian et al. Jun 1998 A
5769894 Ferragamo Jun 1998 A
5772672 Toy et al. Jun 1998 A
5776151 Chan Jul 1998 A
5779706 Tschakaloff Jul 1998 A
5779719 Klein et al. Jul 1998 A
5779728 Lunsford et al. Jul 1998 A
5782862 Bonutti Jul 1998 A
5782925 Collazo et al. Jul 1998 A
5785713 Jobe Jul 1998 A
5792096 Rentmeester et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797963 McDevitt Aug 1998 A
5800537 Bell Sep 1998 A
5800544 Demopulos Sep 1998 A
5806518 Mittelstadt Sep 1998 A
5807403 Beyar et al. Sep 1998 A
5810827 Haines et al. Sep 1998 A
5810853 Yoon Sep 1998 A
5814071 McDevitt et al. Sep 1998 A
5814072 Bonutti Sep 1998 A
5814073 Bonutti Sep 1998 A
5817107 Schaller Oct 1998 A
5823994 Sharkey et al. Oct 1998 A
5824009 Fukuda et al. Oct 1998 A
5827318 Bonutti Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836897 Sakurai et al. Nov 1998 A
5839899 Robinson Nov 1998 A
5843178 Vanney et al. Dec 1998 A
5845645 Bonutti Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5860997 Bonutti Jan 1999 A
5865834 McGuire Feb 1999 A
5866634 Tokushige et al. Feb 1999 A
5868749 Reed Feb 1999 A
5871018 Delp et al. Feb 1999 A
5873891 Sohn Feb 1999 A
5874235 Chan Feb 1999 A
5879372 Bartlett Mar 1999 A
5888196 Bonutti Mar 1999 A
5888219 Bonutti Mar 1999 A
5897559 Masini Apr 1999 A
5897574 Bonutti Apr 1999 A
5899911 Carter May 1999 A
5906579 Vander Salm et al. May 1999 A
5906616 Pavlov et al. May 1999 A
5906625 Bito et al. May 1999 A
5911721 Nicholson et al. Jun 1999 A
5919193 Slavitt Jul 1999 A
5919208 Valenti Jul 1999 A
5921986 Bonutti Jul 1999 A
5925064 Meyers et al. Jul 1999 A
5928267 Bonutti et al. Jul 1999 A
5935094 Zupkas Aug 1999 A
5935131 Bonutti Aug 1999 A
5935149 Ek Aug 1999 A
5941900 Bonutti Aug 1999 A
5948002 Bonutti Sep 1999 A
5954739 Bonutti Sep 1999 A
5957953 DiPoto et al. Sep 1999 A
5961499 Bonutti Oct 1999 A
5961521 Roger Oct 1999 A
5961538 Pedlick et al. Oct 1999 A
5968044 Nicholson et al. Oct 1999 A
5968047 Reed Oct 1999 A
5980520 Vancaillie Nov 1999 A
5980558 Wiley Nov 1999 A
5980559 Bonutti Nov 1999 A
5984967 Zdeblick et al. Nov 1999 A
5989282 Bonutti Nov 1999 A
5989289 Coates et al. Nov 1999 A
6007567 Bonutti Dec 1999 A
6007580 Lehto et al. Dec 1999 A
6010525 Bonutti et al. Jan 2000 A
6013853 Athanasiou et al. Jan 2000 A
6017305 Bonutti Jan 2000 A
6017321 Boone Jan 2000 A
6024746 Katz Feb 2000 A
6033430 Bonutti Mar 2000 A
6042596 Bonutti Mar 2000 A
6045551 Bonutti Apr 2000 A
6050998 Fletcher Apr 2000 A
6056754 Haines et al. May 2000 A
6056772 Bonutti May 2000 A
6056773 Bonutti May 2000 A
6059817 Bonutti et al. May 2000 A
6063095 Wang et al. May 2000 A
6066175 Henderson et al. May 2000 A
6068648 Cole et al. May 2000 A
6074409 Goldfarb Jun 2000 A
6077292 Bonutti Jun 2000 A
6083244 Lubbers et al. Jul 2000 A
6086593 Bonutti Jul 2000 A
6086608 Ek et al. Jul 2000 A
6090072 Kratoska et al. Jul 2000 A
6099531 Bonutti Aug 2000 A
6099537 Sugai et al. Aug 2000 A
6099547 Gellman et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6102928 Bonutti Aug 2000 A
6102955 Mendes et al. Aug 2000 A
6110207 Eichhorn et al. Aug 2000 A
6117160 Bonutti Sep 2000 A
6120536 Ding et al. Sep 2000 A
6123710 Pinczewski Sep 2000 A
6125574 Ganaja et al. Oct 2000 A
6126677 Ganaja et al. Oct 2000 A
6132472 Bonutti Oct 2000 A
6139320 Hahn Oct 2000 A
RE36974 Bonutti Nov 2000 E
6152949 Bonutti Nov 2000 A
6159234 Bonutti et al. Dec 2000 A
6171236 Bonutti Jan 2001 B1
6171299 Bonutti Jan 2001 B1
6174313 Bonutti Jan 2001 B1
6187023 Bonutti Feb 2001 B1
6190400 Van De Moer et al. Feb 2001 B1
6190401 Green et al. Feb 2001 B1
6193754 Seedhom Feb 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6217617 Bonutti Apr 2001 B1
6231592 Bonutti et al. May 2001 B1
6235057 Roger et al. May 2001 B1
6238395 Bonutti May 2001 B1
6238396 Lombardo May 2001 B1
6258091 Sevrain et al. Jul 2001 B1
6277136 Bonutti Aug 2001 B1
6287325 Bonutti Sep 2001 B1
6309405 Bonutti Oct 2001 B1
6312448 Bonutti Nov 2001 B1
6325806 Fox Dec 2001 B1
6338730 Bonutti Jan 2002 B1
6358266 Bonutti Mar 2002 B1
6361565 Bonutti Mar 2002 B1
6364897 Bonutti Apr 2002 B1
6368343 Bonutti et al. Apr 2002 B1
6398797 Bombard et al. Jun 2002 B2
6423063 Bonutti Jul 2002 B1
6428562 Bonutti Aug 2002 B2
6447516 Bonutti Sep 2002 B1
6450985 Schoelling et al. Sep 2002 B1
6451042 Bonutti Sep 2002 B1
6464713 Bonutti Oct 2002 B2
6468289 Bonutti Oct 2002 B1
6468293 Bonutti et al. Oct 2002 B2
6471724 Zdeblick et al. Oct 2002 B2
6475230 Bonutti et al. Nov 2002 B1
6500195 Bonutti Dec 2002 B2
6503267 Bonutti et al. Jan 2003 B2
6503277 Bonutti Jan 2003 B2
6540786 Chibrac et al. Apr 2003 B2
6543455 Bonutti Apr 2003 B2
6569187 Bonutti May 2003 B1
6572635 Bonutti Jun 2003 B1
6575982 Bonutti Jun 2003 B1
D477776 Pontaoe Jul 2003 S
6585750 Bonutti Jul 2003 B2
6592531 Bonutti Jul 2003 B2
6592609 Bonutti Jul 2003 B1
6607534 Bonutti Aug 2003 B2
6620181 Bonutti Sep 2003 B1
6630000 Bonutti Oct 2003 B1
6635073 Bonutti Oct 2003 B2
6638279 Bonutti Oct 2003 B2
6638309 Bonutti Oct 2003 B2
6652532 Bonutti Nov 2003 B2
6702821 Bonutti Mar 2004 B2
6702856 Bonutti Mar 2004 B2
6719765 Bonutti Apr 2004 B2
6719803 Bonutti Apr 2004 B2
6736853 Bonutti May 2004 B2
6770078 Bonutti Aug 2004 B2
6776938 Bonutti Aug 2004 B2
6835198 Bonutti Dec 2004 B2
6860885 Bonutti Mar 2005 B2
6860904 Bonutti Mar 2005 B2
6899722 Bonutti May 2005 B2
6905517 Bonutti Jun 2005 B2
6908466 Bonutti et al. Jun 2005 B1
6932835 Bonutti et al. Aug 2005 B2
6942684 Bonutti Sep 2005 B2
6955683 Bonutti Oct 2005 B2
6989029 Bonutti Jan 2006 B2
6990982 Bonutti Jan 2006 B1
6997940 Bonutti Feb 2006 B2
7001385 Bonutti Feb 2006 B2
7004959 Bonutti Feb 2006 B2
7048755 Bonutti May 2006 B2
7070557 Bonutti Jul 2006 B2
7087073 Bonutti Aug 2006 B2
7094251 Bonutti Aug 2006 B2
7104996 Bonutti Sep 2006 B2
7114500 Bonutti Oct 2006 B2
7128753 Bonutti et al. Oct 2006 B1
7128763 Blatt Oct 2006 B1
7134437 Bonutti Nov 2006 B2
7147652 Bonutti et al. Dec 2006 B2
7208013 Bonutti Apr 2007 B1
7217273 Bonutti May 2007 B2
7217290 Bonutti May 2007 B2
7311719 Bonutti Dec 2007 B2
7329263 Bonutti Feb 2008 B2
7429266 Bonutti Sep 2008 B2
7462200 Bonutti Dec 2008 B2
7481825 Bonutti Jan 2009 B2
7481831 Bonutti Jan 2009 B2
7510557 Bonutti Mar 2009 B1
7615054 Bonutti Nov 2009 B1
7635390 Bonutti Dec 2009 B1
7708740 Bonutti May 2010 B1
7708741 Bonutti May 2010 B1
7727283 Bonutti Jun 2010 B2
7749229 Bonutti Jul 2010 B1
7780670 Bonutti Aug 2010 B2
7806896 Bonutti Oct 2010 B1
7806897 Bonutti Oct 2010 B1
7828852 Bonutti Nov 2010 B2
7837736 Bonutti Nov 2010 B2
7854750 Bonutti et al. Dec 2010 B2
7879072 Bonutti et al. Feb 2011 B2
7892236 Bonutti Feb 2011 B1
7892261 Bonutti Feb 2011 B2
7896880 Bonutti Mar 2011 B2
7931690 Bonutti Apr 2011 B1
7959635 Bonutti Jun 2011 B1
7967820 Bonutti et al. Jun 2011 B2
RE43143 Hayhurst Jan 2012 E
8128669 Bonutti Mar 2012 B2
8133229 Bonutti Mar 2012 B1
8147514 Bonutti Apr 2012 B2
8162977 Bonutti et al. Apr 2012 B2
8425522 Bonutti Apr 2013 B2
8486066 Bonutti Jul 2013 B2
8496657 Bonutti et al. Jul 2013 B2
8617185 Bonutti Dec 2013 B2
8623030 Bonutti Jan 2014 B2
8632552 Bonutti Jan 2014 B2
8641726 Bonutti Feb 2014 B2
8690944 Bonutti Apr 2014 B2
20010023371 Bonutti Sep 2001 A1
20020029055 Bonutti Mar 2002 A1
20020040246 Bonutti Apr 2002 A1
20020095160 Bonutti Jul 2002 A1
20030009147 Bonutti Jan 2003 A1
20030023260 Bonutti Jan 2003 A1
20030032975 Bonutti Feb 2003 A1
20030181800 Bonutti Sep 2003 A1
20040010287 Bonutti Jan 2004 A1
20040097794 Bonutti May 2004 A1
20040098016 Bonutti May 2004 A1
20040127930 Bonutti Jul 2004 A1
20040138689 Bonutti Jul 2004 A1
20040138690 Bonutti Jul 2004 A1
20040143285 Bonutti Jul 2004 A1
20040167548 Bonutti Aug 2004 A1
20040172033 Bonutti Sep 2004 A1
20040193181 Bonutti Sep 2004 A1
20040220616 Bonutti Nov 2004 A1
20040230223 Bonutti Nov 2004 A1
20040254582 Bonutti Dec 2004 A1
20050216059 Bonutti et al. Sep 2005 A1
20050222620 Bonutti Oct 2005 A1
20050240227 Bonutti Oct 2005 A1
20050267534 Bonutti Dec 2005 A1
20060015108 Bonutti Jan 2006 A1
20060089646 Bonutti Apr 2006 A1
20060142799 Bonutti Jun 2006 A1
20060167495 Bonutti Jul 2006 A1
20060200199 Bonutti et al. Sep 2006 A1
20060212073 Bonutti Sep 2006 A1
20060229623 Bonutti et al. Oct 2006 A1
20060235470 Bonutti Oct 2006 A1
20060241695 Bonutti Oct 2006 A1
20060265009 Bonutti Nov 2006 A1
20060265011 Bonutti Nov 2006 A1
20070088362 Bonutti et al. Apr 2007 A1
20070102005 Bonutti May 2007 A1
20070208378 Bonutti et al. Sep 2007 A1
20080021474 Bonutti Jan 2008 A1
20080039845 Bonutti Feb 2008 A1
20080039873 Bonutti et al. Feb 2008 A1
20080047567 Bonutti Feb 2008 A1
20080051799 Bonutti Feb 2008 A1
20080058822 Bonutti Mar 2008 A1
20080065140 Bonutti Mar 2008 A1
20080103519 Bonutti May 2008 A1
20080108916 Bonutti May 2008 A1
20080114399 Bonutti May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080140117 Bonutti Jun 2008 A1
20100211120 Bonutti et al. Aug 2010 A1
20100312350 Bonutti Dec 2010 A1
20110060375 Bonutti Mar 2011 A1
20110295253 Bonutti et al. Dec 2011 A1
20120010623 Bonutti Jan 2012 A1
20120165841 Bonutti Jun 2012 A1
20120191140 Bonutti Jul 2012 A1
20120215226 Bonutti Aug 2012 A1
20120215233 Bonutti et al. Aug 2012 A1
20120221017 Bonutti Aug 2012 A1
20130144389 Bonutti Jun 2013 A1
20130226185 Bonutti Aug 2013 A1
20130226311 Bonutti Aug 2013 A1
20140018852 Bonutti Jan 2014 A1
20140018854 Bonutti Jan 2014 A1
20140025110 Bonutti Jan 2014 A1
20140025111 Bonutti Jan 2014 A1
20140025112 Bonutti Jan 2014 A1
Foreign Referenced Citations (72)
Number Date Country
1312518 Jan 1993 CA
2641580 Aug 2007 CA
2680827 Sep 2008 CA
2698057 Mar 2009 CA
117960 May 1927 CH
337437 May 1921 DE
605255 Nov 1934 DE
1903016 Oct 1964 DE
1903316 Oct 1964 DE
1903016 Aug 1970 DE
2411226 Sep 1974 DE
32 11 682 Oct 1983 DE
35 17 204 Nov 1986 DE
37 07 787 Sep 1988 DE
37 22 538 Jan 1989 DE
90 02 844.9 Jan 1991 DE
0 010 650 May 1980 EP
0 192 576 Aug 1986 EP
0 283 661 Sep 1988 EP
0 287 998 Oct 1988 EP
0 418 147 Mar 1991 EP
0 699 416 Mar 1996 EP
784454 May 1996 EP
0 773 004 May 1997 EP
1614525 Jan 2006 EP
1988837 Aug 2007 EP
2134294 Dec 2009 EP
325846 May 1903 FR
726041 May 1932 FR
1 111 677 Mar 1956 FR
2 344 267 Oct 1977 FR
2 580 504 Oct 1986 FR
2 682 287 Apr 1993 FR
2 717 368 Mar 1994 FR
2 696 338 Apr 1994 FR
2 728 779 Jan 1995 FR
2 736 257 Jul 1995 FR
2 750 031 Jun 1996 FR
2 771 621 Nov 1997 FR
2 785 171 Oct 1998 FR
214913 May 1924 GB
2 093 701 Sep 1982 GB
2 306 110 Apr 1997 GB
S6429266 Jan 1989 JP
8-140982 Jun 1996 JP
H08173436 Jul 1996 JP
3738221 Jan 2006 JP
184396 Jul 1966 SU
1323090 Jul 1987 SU
1367947 Jan 1988 SU
WO 8701270 Mar 1987 WO
WO 8801517 Mar 1988 WO
WO 9112779 Sep 1991 WO
WO 9323094 Nov 1993 WO
WO 9408642 Apr 1994 WO
WO 9516398 Jun 1995 WO
WO 9531941 Nov 1995 WO
WO 9614802 May 1996 WO
WO 9629029 Sep 1996 WO
WO 9712779 Apr 1997 WO
WO 9720522 Jun 1997 WO
WO 9739700 Oct 1997 WO
WO 9749347 Dec 1997 WO
WO 9811838 Mar 1998 WO
WO 9826720 Jun 1998 WO
WO 0134036 May 2001 WO
WO 02053011 Jul 2002 WO
WO 2007092869 Aug 2007 WO
WO 2007092869 Aug 2007 WO
WO 2008116203 Sep 2008 WO
WO 2009029908 Mar 2009 WO
WO 2010099222 Feb 2010 WO
Non-Patent Literature Citations (334)
Entry
U.S. Appl. No. 13/221,043, filed Jun. 2011, Bonutti.
Copending U.S. Appl. No. 09/556,458, Non-Final Rejection mailed Sep. 25, 2002.
Copending U.S. Appl. No. 09/556,458, Response to Office Action Dec. 26, 2002.
Copending U.S. Appl. No. 10/614,352, Examiner Interview Summary Jul. 31, 2007.
Copending U.S. Appl. No. 10/614,352, Final Office Action Jul. 12, 2010.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Jan. 25, 2007.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Apr. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Oct. 2, 2007.
Copending U.S. Appl. No. 10/614,352, non Final Office Action Aug. 10, 2011.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Jan. 15, 2008.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Apr. 17, 2007.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Aug. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Aug. 21, 2008.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Nov. 24, 2009.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Dec. 1, 2005.
Copending U.S. Appl. No. 10/614,352, Request for Continued Examination Sep. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Request for Continued Examination Oct. 30, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Mar. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Mar. 26, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Apr. 26, 2010.
Copending U.S. Appl. No. 10/614,352, Response to Office Action May 15, 2008.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Jul. 17, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Sep. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Oct. 30, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Nov. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Dec. 22, 2008.
Copending U.S. Appl. No. 11/931,823, final Office Action mailed Aug. 2, 2011.
Copending U.S. Appl. No. 11/931,823, Office Action mailed Nov. 24, 2010.
Copending U.S. Appl. No. 11/931,823, Response to Office Action Aug. 9, 2010.
Copending U.S. Appl. No. 11/931,823, RestrictionElect dated Jun. 8, 2010.
Copending U.S. Appl. No. 11/187,482 Response to Office Action Jun. 21, 2011.
Copending U.S. Appl. No. 10/413,696, Non-Final Rejection mailed Sep. 23, 2005.
Copending U.S. Appl. No. 10/413,696, Requirement for Restriction Jun. 8, 2005.
Copending U.S. Appl. No. 10/413,696, Response to Office Action Jul. 5, 2005.
Copending U.S. Appl. No. 10/413,696, Response to Office Action Dec. 20, 2005.
Copending U.S. Appl. No. 11/460,650, mailed Dec. 23, 2009.
Copending U.S. Appl. No. 11/460,650, Final Rejection mailed Apr. 20, 2010.
Copending U.S. Appl. No. 11/460,650, Final Rejection mailed Aug. 29, 2008.
Copending U.S. Appl. 11/460,650, Non-Final Rejection mailed Mar. 10, 2009.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed May 30, 2007.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed Sep. 16, 2009.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed Dec. 28, 2007.
Copending U.S. Appl. No. 11/460,650, Request for Continued Examination Jan. 29, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jan. 12, 2010.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jan. 29, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Mar. 28, 2008.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jun. 10, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Oct. 1, 2007.
Copending U.S. Appl. No. 11/461,110, Final Rejection mailed Dec. 8, 2009.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed Apr. 22, 2009.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed Jun. 6, 2008.
Copending U.S. Appl. No. 11/461,110, Request for Continued Examination Mar. 12, 2008.
Copending U.S. Appl. No. 11/461,110, Request for Continued Examination Jun. 8, 2010.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Mar. 12, 2008.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Jun. 8, 2010.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Sep. 22, 2009.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Oct. 6, 2008.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Oct. 15, 2007.
Copending U.S. Appl. No. 11/461,110, Final Rejection mailed Dec. 12, 2007.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed May 14, 2007.
Copending U.S. Appl. No. 11/930,621, Final Rejection Jun. 22, 2010.
Copending U.S. Appl. No. 11/930,621, Non-Final Rejection mailed Sep. 21, 2009.
Copending U.S. Appl. No. 11/930,621, Response to Office Action Mar. 22, 2010.
Copending U.S. Appl. No. 09/524,397, Final Rejection mailed Jun. 15, 2001.
Copending U.S. Appl. No. 09/524,397, Non-Final Rejection mailed Dec. 18, 2000.
Copending U.S. Appl. No. 09/524,397, Response to Office Action Mar. 19, 2001.
Copending U.S. Appl. No. 09/524,397, Response to Office Action Oct. 15, 2001.
Copending U.S. Appl. No. 10/458,117, Advisory Action Jan. 20, 2006.
Copending U.S. Appl. No. 10/458,117, Examiner Interview Summary mailed May 16, 2008.
Copending U.S. Appl. No. 10/458,117, Non-Final Rejection mailed Mar. 22, 2005.
Copending U.S. Appl. No. 10/458,117, Non-Final Rejection mailed Nov. 15, 2006.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Feb. 26, 2008.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Feb. 21, 2006.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Aug. 3, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Feb. 13, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Jun. 22, 2005.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Aug. 3, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Nov. 8, 2005.
Copending U.S. Appl. No. 10/458,117, Final Rejection mailed May 3, 2007.
Copending U.S. Appl. No. 10/458,117, Final Rejection mailed Sep. 8, 2005.
Copending U.S. Appl. No. 11/370,775, mailed Oct. 29, 2007.
Copending U.S. Appl. No. 11/370,775, mailed Apr. 24, 2008.
Copending U.S. Appl. No. 11/370,775, mailed Feb. 27, 2009.
Copending U.S. Appl. No. 11/370,775, Examiner Interview Summary mailed Aug. 28, 2009.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Feb. 6, 2007.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Jan. 22, 2008.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Oct. 15, 2008.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Nov. 6, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Jun. 4, 2007.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Oct. 26, 2007.
Copending U.S. Appl. No. 11/370,775, Response to Office Action May 22, 2008.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Jan. 15, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Aug. 13, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action May 6, 2010.
Copending U.S. Appl. No. 11/370,775, Supplemental Response to Office Action Jan. 30, 2009.
Copending U.S. Appl. No. 11/370,775, Final Rejection mailed Aug. 31, 2007.
Copending U.S. Appl. No. 11/370,775, Final Rejection mailed Mar. 13, 2009.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Oct. 26, 2007.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Jan. 10, 2011.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Aug. 13, 2009.
Copending U.S. Appl. No. 11/456,132, mailed Aug. 28, 2009.
Copending U.S. Appl. No. 11/456,132, Request for Continued Examination Jun. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Jan. 7, 2009.
Copending U.S. Appl. No. 11/456,132, Response filed Jan. 18, 2012.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Apr. 14, 2011.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Apr. 19, 2010.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Jun. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Aug. 13, 2009.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Nov. 19, 2007.
Copending U.S. Appl. No. 11/456,132, Final Rejection mailed Mar. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Final Rejection mailed Dec. 18, 2009.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Mar. 13, 2009.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Jun. 18, 2007.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Oct. 7, 2008.
Copending U.S. Appl. No. 11/456,221, Final Rejection mailed Feb. 22, 2008.
Copending U.S. Appl. No. 11/456,221, Final Rejection mailed Mar. 24, 2010.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Jul. 6, 2009.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Jul. 9, 2007.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Oct. 29, 2008.
Copending U.S. Appl. No. 11/456,221, Request for Continued Examination Jun. 19, 2008.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Jan. 6, 2010.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Mar. 30, 2009.
Copending U.S. Appl. No. 11/456,221, Response to Office Action May 22, 2008.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Nov. 9, 2007.
Copending U.S. Appl. No. 11/932,051, Final Office Action mailed Jun. 9, 2011.
Copending U.S. Appl. No. 11/932,051, RCE Response Dec. 9, 2011.
Copending U.S. Appl. No. 11/932,051, Requirement for Restriction Jan. 22, 2010.
Copending U.S. Appl. No. 10/228,855, Non-Final Rejection mailed Sep. 28, 2005.
Copending U.S. Appl. No. 10/228,855, Response to Office Action Dec. 28, 2005.
Copending U.S. Appl. No. 11/465,199, Response to Office Action Jun. 28, 2010.
Copending U.S. Appl. No. 11/465,199, Non-Final Rejection mailed Dec. 28, 2009.
Copending U.S. Appl. No. 11/932,602, Final Response to Office Action Jun. 10, 2011.
Copending U.S. Appl. No. 11/932,602, non final Office Action Oct. 6, 2010.
Copending U.S. Appl. No. 11/932,602, Response to Office Action Apr. 6, 2011.
Copending U.S. Appl. No. 12/359,364, Final Office Action Apr. 7, 2011.
Copending U.S. Appl. No. 11/438,537, RCE Response Nov. 21, 2011.
Copending U.S. Appl. No. 11/932,907, RCE Response Sep. 15, 2011.
Copending U.S. Appl. No. 11/932,907, non-final Office Action Nov. 17, 2010.
Copending U.S. Appl. No. 11/932,907, Response to Office Action Apr. 18, 2011.
Copending U.S. Appl. No. 11/133,730, Final Office action Aug. 17, 2011.
Copending U.S. Appl. No. 11/169,475, Response Sep. 2, 2011.
Copending U.S. Appl. No. 11/169,475, Office Action Mar. 2, 2011.
Copending U.S. Appl. No. 11/126,543, non Final Office Action Aug. 10, 2011.
Copending U.S. Appl. No. 11/126,543, RCE Response filed Jun. 30, 2011.
Copending U.S. Appl. No. 10/780,444, Examiner Interview Summary mailed Nov. 20, 2009.
Copending U.S. Appl. No. 10/780,444, Final Rejection mailed Mar. 30, 2010.
Copending U.S. Appl. No. 10/780,444, Final Rejection mailed Dec. 23, 2008.
Copending U.S. Appl. No. 10/780,444, nonFinal Office Action Aug. 9, 2011.
Copending U.S. Appl. No. 10/780,444, Non-Final Rejection mailed Mar. 11, 2008.
Copending U.S. Appl. 10/780,444, Non-Final Rejection mailed Jul. 7, 2009.
Copending U.S. Appl. No. 10/780,444, Request for Continued Examination Apr. 23, 2009.
Copending U.S. Appl. No. 10/780,444, Requirement for Restriction Sep. 12, 2007.
Copending U.S. Appl. No. 10/780,444, Requirement for Restriction Apr. 10, 2007.
Copending U.S. Appl. No. 10/780,444, Response filed Feb. 9, 2012.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Apr. 23, 2009.
Copending U.S. Appl. No. 10/780,444, Response to Office Action May 10, 2007.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Jul. 9, 2008.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Oct. 12, 2007.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Dec. 4, 2009.
Copending U.S. Appl. No. 10/779,978, Non-Final Office Action mailed Jan. 13, 2011.
Copending U.S. Appl. No. 10/779,978, Final Rejection mailed Feb. 3, 2009.
Copending U.S. Appl. No. 10/779,978, Final Rejection mailed May 14, 2010.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Jun. 18, 2008.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Aug. 3, 2007.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Oct. 1, 2009.
Copending U.S. Appl. No. 10/779,978, Request for Continued Examination Jul. 6, 2009.
Copending U.S. Appl. No. 10/779,978, Requirement for Restriction Apr. 20, 2007.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Feb. 1, 2010.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Mar. 25, 2008.
Copending U.S. Appl. No. 10/779,978, Response to Office Action May 21, 2007.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Jul. 6, 2009.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Jul. 13, 2011.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Oct. 20, 2008.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Dec. 3, 2007.
Copending U.S. Appl. No. 10/797,685, Examiner Interview Summary mailed Sep. 11, 2007.
Copending U.S. Appl. No. 10/797,685, Final Rejection mailed Apr. 25, 2007.
Copending U.S. Appl. No. 10/797,685, Non-Final Rejection mailed Nov. 17, 2006.
Copending U.S. Appl. No. 10/797,685, Response to Office Action Feb. 20, 2007.
Copending U.S. Appl. No. 10/797,685, Response to Office Action Aug. 27, 2007.
Copending U.S. Appl. No. 11/874,323, Office Action mailed Jul. 6, 2011.
Copending U.S. Appl. 11/874,323, Response filed Apr. 21, 2011.
Copending U.S. Appl. No. 11/258,795, Non-Final Office Action mailed Apr. 26, 2011.
Copending U.S. Appl. No. 11/202,294, Office Action mailed Jun. 24, 2011.
Copending U.S. Appl. No. 11/202,294, Response filed Dec. 24, 2011.
Copending U.S. Appl. No. 11/358,399, non Final Office Action Jan. 3, 2011.
Copending U.S. Appl. No. 11/358,399, Response filed Jul. 5, 2011.
Copending U.S. Appl. No. 11/671,556, Final Office Action mailed Nov. 12, 2010.
Copending U.S. Appl. No. 11/671,556, Response filed Aug. 23, 2010.
Copending U.S. Appl. No. 11/671,556, Non-Final Rejection mailed Feb. 22, 2010.
Copending U.S. Appl. No. 11/671,556, Requirement for Restriction Sep. 1, 2009.
Copending U.S. Appl. No. 11/671,556, Response to Office Action Nov. 2, 2009.
Copending U.S. Appl. No. 11/416,618, Examiner Interview Summary mailed Apr. 15, 2010.
Copending U.S. Appl. No. 11/416,618, Final Rejection mailed Jun. 24, 2009.
Copending U.S. Appl. No. 11/416,618, Non-Final Rejection mailed Oct. 13, 2009.
Copending U.S. Appl. No. 11/416,618, Non-Final Rejection mailed Nov. 26, 2008.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Mar. 15, 2010.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Mar. 26, 2009.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Apr. 16, 2010.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Sep. 24, 2009.
Copending U.S. Appl. No. 11/416,618, Request for Continued Examination Dec. 8, 2011.
Copending U.S. Appl. No. 11/689,670, Final Office Action mailed Mar. 17, 2011.
Copending U.S. Appl. No. 11/689,670, RCE Response Sep. 19, 2011.
Copending U.S. Appl. No. 11/689,670, Requirement for Restriction Mar. 15, 2010.
Copending U.S. Appl. No. 11/689,670, Response to Office Action Jan. 3, 2011.
Copending U.S. Appl. No. 11/689,670, Response to Office Action Apr. 15, 2010.
Copending U.S. Appl. No. 12/202,210, Requirement for Restriction mailed Aug. 16, 2011.
Copending U.S. Appl. No. 12/202,210, Response filed Dec. 16, 2011.
Co-pending U.S. Appl. No. 11/438,537, Supplemental Final Rejection mailed Sep. 25, 2009.
File History of U.S. Patent No. 5,403,348; U.S. Appl. No. 08/062,295, filed May 14, 1993; 231 pages.
File History of U.S. Patent No. 5,522,846; U.S. Appl. No. 08/402,352, filed Mar. 10, 1995; 215 pages.
History of U.S. Patent No. 5,527,343; U.S. Appl. No. 08/344,466, filed Nov. 23, 1994; 246 pages.
File History of U.S. Patent No. 5,549,630; U.S. Appl. No. 08/291,970, filed Aug. 17, 1994; 276 pages.
File History of U.S. Patent No. 5,980,559; U.S. Appl. No. 08/964,167, filed Nov. 4, 1997; 57 pages.
File History of U.S. Patent No. 6,500,195; U.S. Appl. No. 09/872,033, filed Jun. 1, 2001; 522 pages.
File History of U.S. Patent No. 7,087,073; U.S. Appl. No. 10/413,696, filed Apr. 14, 2003; 13 pages.
Petition for Inter Partes Review of U.S. Patent No. 5,980,559 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 24, 2013; IPR2013-00603; with exhibits, 382 pages.
Declaration of David Kaplan, PH.D. Regarding U.S. Patent No. 5,980,559, IPR 2013-00603, Sep. 24, 2013; 86 pages.
Petition for Inter Partes Review of U.S. Patent No. 7,087,073 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 24, 2013; IPR2013-00604; with exhibits, 243 pages.
Declaration of Wayne J. Sebastianelli, MD Regarding U.S. Patent No. 7,087,073, Sep. 24, 2013, IPR 2013-00604; 82 pages.
Petition for Inter Partes Review of U.S. Patent No. 6,500,195 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 25, 2013; IPR2013-00624; with exhibits, 1152 pages.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Patent No. 6,500,195, IPR 2013-00624; Sep. 25, 2013; 28 pages.
Petition for Inter Partes Review of U.S. Patent No. 5,527,343 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 26, 2013; IPR2013-00628; with exhibits, 882 pages.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Patent No. 5,527,343, IPR 2013-00628, Sep. 25, 2013; 65 pages.
Corrected Petition for Inter Partes Review of U.S. Patent No. 5,921,986 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et Seq.; filed Oct. 11, 2013; IPR2013-00631; with exhibits, 285 pages.
Expert Declaration of Steve E. Jordan, MD, for Inter Partes Review of U.S. Patent No. 5,921,986, IPR 2013-00631, Sep. 24, 2013; 39 pages.
Corrected Petition for Inter Partes Review of U.S. Patent No. 8,147,514 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et Seq.; filed Oct. 11, 2013; IPR2013-00632; with exhibits, 268 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 8,147,514, IPR 2013-00631, dated Sep. 23, 2013, 38 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 8,147,514, IPR 2013-00632 and IPR 2013-00633, Sep. 23, 2013; (exhibits 1006 & 1009); 61 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 5,921,986, from IPR 2013-00632, dated Sep. 24, 2013 (exhibit 1010); 39 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 5,921,986, from IPR 2013-00633, dated Sep. 24, 2013 (exhibit 1007); 39 pages.
Corrected Petition for Inter Partes Review of U.S. Patent No. 8,147,514 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et. Seq.; filed Oct. 11, 2013; IPR2013-00633; with exhibits, 248 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants Linvatec and ConMed Corporation's Invalidity Contentions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Sep. 30, 2013; 2703 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants Linvatec and ConMed Corporation's Non-Infringement Contentions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Sep. 30, 2013; 310 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants' Proposed Claim Term Constructions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 1, 2013; 53 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants' Proposed Terms for Construction;” Case No. 6:12-cv-01379; M.D. Florida; Oct. 10, 2013; 9 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Joint Claim Construction Statement;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 15, 2013; 55 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Plaintiff Bonutti Skeletal Innovations LLC's Initial Identification of Disputed Claim Terms;” Case No. 6:12-cv-01379; M.D. Florida; Oct. 10, 2013; 3 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Plaintiff Bonutti Skeletal Innovations LLC's Proposed Interpretations of Disputed Claim Terms;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 1, 2013; 35 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Order;” Case No. 6:12-cv-1379-0rl-22TBS; M.D. Florida; Mar. 25, 2014; 22 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex Inc.'s Preliminary Identification of Proposed Claim Terms for Construction by the Court;” Case No. 6:12-cv-01380; M.D. Florida; Mar. 15, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex Inc.'s Preliminary Identification of Proposed Claim Terms for Construction by the Court;” Case No. 6:13-cv-00620; M.D. Florida; Oct. 16, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Disclosure of Preliminary Non-Infringement and Invalidity Contentions;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Sep. 23, 2013; 1751 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Notice of a First Supplemental Disclosure of Preliminary Invalidity Contentions;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Oct. 24, 2013; 660 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Preliminary Constructions of Terms Proposed for Construction by the Court;” Case No. 6:13-cv-01380; M.D. Florida; Mar. 25, 2013; 11 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Preliminary Constructions of Terms Proposed for Construction by the Court;” With Exhibit; Case No. 6:12-cv-00620; M.D. Florida; Nov. 1, 2013; 27 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Supplemental Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Nov. 15, 2013; 9 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “First Amended Complaint with Exhibits” Case No. 6:12-cv-01380; M.D. Florida; Sep. 21, 2012; 259 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Joint Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Nov. 15, 2013; 25 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Consent Joint Motion for Leave to File Corrected Joint Claim Construction Statement Exhibit;” Case No. 6:13-cv-00620; M.D. Florida; Dec. 12, 2013; 23 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Notice of Filing Corrected Joint Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Dec. 23, 2013; 21 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Plaintiff Bonutti Skeletal Innovations LLC's Proposed Interpretations of Disputed Claim Terms;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Nov. 1, 2013; 34 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Plaintiff's Initial Preliminary Identification of Claim Terms and Phrases Potentially Needing Interpretation by the Court;” Case No. 6:13-cv-01380; M.D. Florida; Mar. 15, 2013; 5 pages.
Bonutti Skeletal Innovation LLC v. Arthrex, Inc., “Order,” Case No. 6:13-cv-620; M.D. Florida, Mar. 25, 2014, 29 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Declaration of Stephen M. Belkoff, Ph.D in Support of Plaintiff Bonutti Skeletal Innovations LLC's Preliminary Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 49 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' List of Proposed Claim Terms and Phrases for Interpretation;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 3, 2013; 6 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Preliminary Invalidity Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Aug. 29, 2013; 73 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Preliminary Non-Infringement Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Aug. 29, 2013; 86 pagesq.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Proposed Claim Constructions;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 10, 2013; 7 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Depuy's Opening Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 35 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Joint Appendices A through I;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 413 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations Llc's Claim Construction Reply Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Jan. 16, 2014; 24 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's List of Proposed Claim Terms and Phrases for Interpretation;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 3, 2013; 4 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's Preliminary Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 27 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's Response to Defendants' Proposed Claim Constructions;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 30, 2013; 14 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff's Initial Preliminary Infringement Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; May 30, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “DePuy's Reply Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Jan. 16, 2014; 23 pages.
510k Summary of Safety and Effectiveness; “Mitek Micro Anchor;” Jun. 28, 1996; K962511; 1 page.
Amis, Andrew A.; “Anterior Cruciate Ligament Graft Positioning, Tensioning, and Twisting;” Knee Surgery, Sports Traumatology, Arthroscopy, 6 [Suppl. 1]; 1998; pp. S2-S12.
Amis, Andrew A.; “Anterior Cruciate Ligament Replacement, Knee Stability and the Effects of Implants;” The Journal of Bone and Joint Surgery, 71-B; 1989; pp. 819-824.
Arthrex, Protect your graft, Am J Sports Med, vol. 22, No. 4, Jul.-Aug. 1994.
Ask Oxford projection, compact oxford English dictionary: projection, Mar. 30, 2009.
Ask Oxford projection, compact oxford English dictionary: slit, Mar. 30, 2009.
Barber, F. Alan, et al.; “Suture Anchor Failure Strength—An in Vivo Study;” Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 9, No. 6; 1993; pp. 647-652.
Barber, F. Alan; “The Ultimate Strength of Suture Anchors;” Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 11, No. 1; Feb. 1995, pp. 21-28.
Barrett, Gene R., et al.; “T-Fix Endoscopic Meniscal Repair: Technique and Approach to Different Types of Tears;” Arthroscopy, vol. 11, No. 2; Apr. 1995; pp. 245-251.
Barrows, Thomas H., et al.; “Synthetic Bioabsorbable Polymers;” High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications 243 (Michael Szycher ed.); 1991.
Biomet, Stanmore Modular Hip, J. Bone Joint Surg., vol. 76-78: No. Two, Mar. 1994.
Branson, Polymers: Characteristics and Compatibility for Ultrasonic Assembly, Applied Technologies Group, 1971, 4 pages.
Bylski-Austrow, D.I., et al.; “Anterior Cruciate Ligament Replacements: A Mechanical Study of Femoral Attachment Location, Flexion Angle at Tensioning, and Initial Tension;” Journal of Orthopaedic Research, 8; 1990; pp. 522-531.
Cobb, Tyson K., et al.; “Late Correction of Malunited Intercondylar Humeral Fractures Intra-Articular Osteotomy and Tricortical Bone Grafting;” J Bone Joint Surg [Br] 1994; 76-B; pp. 622-626.
Cope, Constantin; “Suture Anchor for Visceral Drainage;” AJR, vol. 146; pp. 160-162; Jan. 1986.
European Search Report dated Sep. 10, 2012 for EP08732724.3 (046).
Flory, Principles of Polymer Chemistry, 1953, selected pp. 576-595, (cited in IPR 2013-00603, exhibit 1012).
Gao et al., Swelling of Hydroxypropyl Methylcellulose Matrix Tablets, 2. Mechanistic Study of the Influence of Formulation Variables on Matrix Performance and Drug Release, J. of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, p. 732-740.
Gopferich, Mechanisms of polymer degradation and erosion, Biomaterials, 1996, vol. 17, No. 2, p. 103-114.
Grizzi; “Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence;” Biomaterials, 1995, vol. 16, No. 4; pp. 305-311.
Grumbine, et al.; “Grappling Suture Fixation Technique;” Clin Podiatr Med Surg. 3(2); 1986; pp. 235-239.
Guide to Ultrasonic Plastics Assembly, Dukane Corporation, Ultrasonic Division Publication, (c) 1995.
Hanna, et al.; “Repair of Distal Tendo Achillis Rupture With the Use of the Mitek Anchor System;” J Am Podiatr Med Assoc, 83(12); Dec. 1993; pp. 663-668.
Hecker, Aaron T., et al.; “Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs;” The American Journal of Sports Medicine, vol. 21, No. 6; Nov.-Dec. 1993; cover page and pp. 874-879.
Hernigou, PH., et al.; “Proximal Tibial Osteotomy for Osteoarthritis with Varus Deformity A Ten To Thirteen-Year Follow-Up Study;” J Bone Joint Surg, vol. 69-A, No. 3.; Mar. 1987; pp. 332-354.
Intl Prelim Rep on Patentability and Written Opinion for PCT/US10/25263 dated Aug. 30, 2011.
IPER—International Preliminary Report on Patentability, WO/2007/092869, published Aug. 12, 2008 for PCT/US2007/061730.
IPER—International Preliminary Report on Patentability, WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948.
IPER—International Preliminary Report on Patentability, WO/2009/029908, published Mar. 2, 2010 for PCT/US2008/074941.
IPR—International Publication WO/2007/092869, published Aug. 16, 2007 for PCT/US2007/061730.
IPR—International Publication WO/2008/116203, published Sep. 25, 2008 for PCT/US08/57948.
IPR—International Publication WO/2009/029908, published May 3, 2009 for PCT/US08/79491.
ISR—International Search Report PCT/US2010/025263 completed Apr. 13, 2010.
ISR—International Search Report WO/2007/092869, published Dec. 13, 2007 for PCT/US2007/061730.
ISR—International Search Report WO/2008/116203, published Dec. 24, 2008 for PCT/US08/57948.
ISR—International Search Report, WO/2009/029908, published May 3, 2009 for PCT/US08/029908.
ISR—International Search Report, WO/2009/029908, published Oct. 28, 2008 for PCT/US2008/074941.
Karlsson, J. et al; “Repair of Bankart Lesions With a Suture Anchor in Recurrent Dislocation of the Shoulder;” Scand. J. of Med & Science in Sports, 1995, 5; pp. 170-174.
Kurosaka, Masahiro, et al.; “A Biomechanical Comparison of Different Surgical Techniques of Graft Fixation in Anterior Cruciate Ligament Reconstruction;” The American Journal of Sports Medicine, vol. 15, No. 3; 1987; pp. 225-229.
Lambert, Kenneth L.; “Vascularized Patellar Tendon Graft with Rigid Internal Fixation for Anterior Cruciate Ligament Insufficiency;” Clinical Orthopaedics and Related Research, No. 172; Jan.-Feb. 1983; pp. 85-89.
Ming Li; Structure-Property Relationships in the Case of the Degradation of Massive Aliphatic Poly-(α-Hydroxy Acids) in Aqueous Media (Parts 1-3) Journals of Materials Science: Materials in Medicine 1; 1990; pp. 123-139 and 198-206.
Mosca, Vincent S., et al.; “Calcaneal Lengthening for Valgus Deformity of the Hindfoot: Results In Children Who Had Severe, Symptomatic Flatfoot And Skewfoot;” J Bone Joint Surg, vol. 77-A, No. 4; Apr. 1995; pp. 500-512.
Nabors, Erric D., et al.; “Anterior Cruciate Ligament Graft Tensioning in Full Extension;” The American Journal of Sports Medicine, vol. 23, No. 4; 1995; pp. 488-492.
Obrist, J. et al.; “Bankart Operation With the Mitek Anchor System;” Unfallchirurgie, 17(4); Aug. 1991; pp. 208-212.
Packer, G.J., et al.; “Repair Of Acute Scapho-Lunate Dissociation Facilitated By The ‘Tag’* Suture Anchor;” Journal of Hand Surgery (British and European Volume, 1994) 19B: 5; pp. 563-564.
Richmond, John C., et al.; “Modification of the Bankart Reconstruction with a Suture Anchor;” Am J Sports Med, vol. 19, No. 4; 1991; p. 343-346.
Seitz, William, et al.; “Repair of the Tibiofibular Syndesmosis with a Flexible Implant;” Journal of Orthopaedic Trauma, vol. 5, No. 1; 1991; pp. 78-82.
Shelton, W., et al.; “Meniscus Replacement with Bone Anchors: A Surgical Technique;” Arthroscopy: The Journal of Arcioscopic and Related Surgery, 10(3); Jun. 1994; pp. 324-327.
Snyder, SJ; “Evaluation and Treatment of the Rotator Cuff;” Orthop Clin North Am, 24(1); Jan. 1993; pp. 173-192.
Steiner, Mark E., et al.; “Anterior Cruciate Ligament Graft Fixation;” The American Journal of Sports Medicine, vol. 22, No. 2; 1994; pp. 240-247.
Taylor, David E., et al.; “Femoral Bone Plug Recession in Endoscopic Anterior Cruciate Ligament Reconstruction;” Arthoscopy: The Journal of Arthroscopic and Related Surgery, vol. 12, No. 4; Aug. 1996; pp. 513-515.
Textured Surface Technology, Branson Technolog, Branson Technolog TL 4, Branson Ultrasonics Corp., (c) 1992.
Tfix; Acufex just tied the knot between endoscopic surgery and meniscal repair; Am. J. Sports Med., vol. 22, No. 3, May-Jun. 1994; 2 pages.
Translation of FR2696338 with translator's certificate dated Sep. 17, 2013 (cited in IPR 2013-00631, 2013-00632).
Translation of DE9002844.9 with translator's certificate dated Sep. 26, 2013 (cited in IPR 2013-00631, 2013-00632).
Verhaven, E., et al.; “Surgical Treatment of Acute Biceps Tendon Ruptures With a Suture Anchor;” Acta Orthop Belg, 59(4); 1993; pp. 426-429.
Van Heerwaarden, R.J., et al.; “Effect of Pretension in Reconstructions of the Anterior Cruciate Ligament With a Dacron Prosthesis;” Knee Surgery, Sports Traumatology, Arthroscopy, 3; 1996; pp. 202-208.
Westrich, et al.; “Isolated Rupture and Repair of the Popliteus Tendon;” Arthoscopy, 11(5); Oct. 1995; pp. 628-632.
Written Opinion for PCT/US2010/025263 completed Apr. 13, 2010.
Written Opinion WO/2007/092869 dated Aug. 7, 2008 for PCT/US2007/061730.
Written Opinion WO/2008/116203 dated Oct. 23, 2008 for PCT/US08/57948.
Written Opinion WO2009/029908 date Feb. 28, 2010 for PCT/US08/74941.
Yamamoto, Yuhei, et al.; “Application of a Suture Anchor Technique for Flap Fixation to Bone;” Journal of Reconstructive Microsurgery; Jul. 1996, vol. 12, No. 5, pp. 313-315.
Yoshiya, Shinichi, et al.; “Graft Tension in Anterior Cruciate Ligament Reconstruction;” The American Journal of Sports Medicine, vol. 15, No. 5; 1987, pp. 464-470.
Copending U.S. Appl. No. 11/230,020, Final Office Action dated Aug. 2, 2011.
Copending U.S. Appl. No. 12/030,728, Response to Office Action Sep. 21, 2011.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Memorandum and Order on Claim Construction;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; May 2, 2014; 22 pages.
U.S. Appl. No. 14/282,908, May 2014, Bonutti.
Related Publications (1)
Number Date Country
20140018853 A1 Jan 2014 US
Divisions (1)
Number Date Country
Parent 08699553 Aug 1996 US
Child 08964167 US
Continuations (5)
Number Date Country
Parent 11230020 Sep 2005 US
Child 14029076 US
Parent 10442353 May 2003 US
Child 11230020 US
Parent 09703058 Oct 2000 US
Child 10442353 US
Parent 09378190 Aug 1999 US
Child 09703058 US
Parent 08964167 Nov 1997 US
Child 09378190 US